<SEC-DOCUMENT>0001683168-20-003793.txt : 20201110
<SEC-HEADER>0001683168-20-003793.hdr.sgml : 20201110
<ACCEPTANCE-DATETIME>20201109210508
ACCESSION NUMBER:		0001683168-20-003793
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20201109
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201110
DATE AS OF CHANGE:		20201109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		201299399

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>radnet_i8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:RDNT="http://radnet.com/20201109">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_03F_RDNT_radnet.com_20201109 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20201109_20201109_zCN5YF347B9i -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0000790526 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2020-11-09to2020-11-09" name="dei:EntityCentralIndexKey">0000790526</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2020-11-09to2020-11-09" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="rdnt-20201109.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2020-11-09to2020-11-09">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-09</xbrli:startDate>
        <xbrli:endDate>2020-11-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 14pt"><b>UNITED
STATES </b></span></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 14pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span><b> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549 </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 14pt"><b>FORM <span id="xdx_900_edei--DocumentType_c20201109__20201109_zsQon74Ku1X8"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" name="dei:DocumentType">8-K</ix:nonNumeric></span>
</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<span id="xdx_90C_edei--DocumentPeriodEndDate_c20201109__20201109_zMGYZHkCKjHf"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">November 9, 2020</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 14pt"><b><span id="xdx_90F_edei--EntityRegistrantName_c20201109__20201109_zF7ligXrXydh"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" name="dei:EntityRegistrantName">RadNet,
Inc.</ix:nonNumeric></span></b></span><b> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 34%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 32%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 32%">&#160;</td></tr>
<tr>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20201109__20201109_zVSgpTRbsnlc"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_edei--EntityFileNumber_c20201109__20201109_zlK9hSVBAxi4"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" name="dei:EntityFileNumber">001-33307</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20201109__20201109_zI8yFH4kQGw8"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" name="dei:EntityTaxIdentificationNumber">13-3326724</ix:nonNumeric></span></span></td></tr>
<tr>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">(State or other jurisdiction of incorporation)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">(Commission File Number)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif">(IRS Employer<br />
Identification Number)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90C_edei--EntityAddressAddressLine1_c20201109__20201109_zTynrK4IabC9"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" name="dei:EntityAddressAddressLine1">1510 Cotner Avenue</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_908_edei--EntityAddressCityOrTown_c20201109__20201109_zjO3TDS0SHs5"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" name="dei:EntityAddressCityOrTown">Los Angeles</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20201109__20201109_zCQpilZ1zJ1j"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span> <span id="xdx_901_edei--EntityAddressPostalZipCode_c20201109__20201109_zwrQ8NRJuGp2"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" name="dei:EntityAddressPostalZipCode">90025</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of
Principal Executive Offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90E_edei--CityAreaCode_c20201109__20201109_zSR39pVJbP77"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" name="dei:CityAreaCode">(310)</ix:nonNumeric></span> <span id="xdx_90E_edei--LocalPhoneNumber_c20201109__20201109_zKWcjsMlV7Ka"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" name="dei:LocalPhoneNumber">445-2800</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s Telephone
Number, Including Area Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Check&#160;the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see </i>General
Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 3%"><span style="font-family: Wingdings"><span id="xdx_90C_edei--WrittenCommunications_c20201109__20201109_zMf83KLluZX3"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 94%"><span style="font-family: Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 3%"><span style="font-family: Wingdings"><span id="xdx_90E_edei--SolicitingMaterial_c20201109__20201109_zlGyAjYPsZz4"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 94%"><span style="font-family: Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 3%"><span style="font-family: Wingdings"><span id="xdx_90F_edei--PreCommencementTenderOffer_c20201109__20201109_zUiY3EIaP2wj"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 94%"><span style="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 3%"><span style="font-family: Wingdings"><span id="xdx_903_edei--PreCommencementIssuerTenderOffer_c20201109__20201109_ze21zEfTfHn5"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 94%"><span style="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 34%">&#160;</td>
    <td style="vertical-align: top; width: 33%">&#160;</td>
    <td style="width: 33%">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration: underline">Title of Each Class</span></span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration: underline">Trading Symbol(s)</span></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration: underline">Name of each exchange on which registered</span></span></td></tr>
<tr>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_edei--Security12bTitle_c20201109__20201109_za23pDRF8tY7"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" name="dei:Security12bTitle">Common Stock, $.0001 par value</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_edei--TradingSymbol_c20201109__20201109_zvwA3mZEQ9V5"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" name="dei:TradingSymbol">RDNT</ix:nonNumeric></span></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_edei--SecurityExchangeName_c20201109__20201109_zU3MYngGMdZ1"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Emerging growth company <span style="font-family: Wingdings"><span id="xdx_906_edei--EntityEmergingGrowthCompany_c20201109__20201109_zzKCtu35zLp2"><ix:nonNumeric contextRef="From2020-11-09to2020-11-09" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: rgb(0, 0, 0); text-indent: 0px; background-color: rgb(255, 255, 255)"></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in">Item 2.02</td><td>RESULTS OF OPERATIONS AND FINANCIAL CONDITION</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November 9, 2020
RadNet, Inc. (&#8220;RadNet&#8221;) issued a press release and held a conference call regarding our 2020 financial results for
the third quarter ended September 30, 2020. A copy of the press release is furnished as Exhibit 99.1 and a copy of the transcript
of the conference call is furnished as Exhibit 99.2 to this Current Report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information in
this Current Report, including Exhibit 99.1 and Exhibit 99.2 is being furnished and shall not be deemed &#8220;filed&#8221; for
purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. The information
in this Current Report, including Exhibit 99.1 and Exhibit 99.2 shall not be incorporated by reference into any registration statement
or other document filed with the Commission.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 9.01</b></td><td style="text-align: justify"><b>FINANCIAL STATEMENTS AND EXHIBITS.</b></td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="font-weight: normal"><span style="text-decoration: underline">Exhibit Number</span></span></td>
    <td style="padding-left: 10pt; text-indent: -10pt"><span style="text-decoration: underline">Description of Exhibit</span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt; width: 15%"><span style="font-weight: normal">99.1</span></td>
    <td style="text-align: left; width: 85%"><span style="font-weight: normal"><a href="radnet_ex9901.htm">Press Release dated November 9, 2020 relating to RadNet, Inc.&#8217;s financial results for the quarter ended September 30, 2020.</a></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">99.2</td>
    <td style="padding-left: 10pt; text-indent: -10pt"><a href="radnet_ex9902.htm">Transcript of conference call.</a></td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td>
    <td style="padding-left: 10pt; text-indent: -10pt">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-left: 10pt; text-indent: -10pt">104</td>
    <td style="padding-left: 10pt; text-indent: -10pt">The cover page from this Current Report on Form 8-K, formatted in Inline XBRL</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-indent: -2.5in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">SIGNATURE</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 29%">Date:&#160;&#160;&#160;November 9, 2020</td>
    <td style="width: 71%; padding-left: 0.3in; text-indent: 1.2in"><b>RADNET, INC.</b></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#160;</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">By: <span style="text-decoration: underline">/s/ Mark D. Stolper </span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Name: Mark D. Stolper</p>
	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"> Title: Chief Financial Officer</p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in">&#160;</p></td></tr>
</table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT INDEX</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">                                                                                                                                          <tr style="vertical-align: top">
<td><b><span style="text-decoration: underline">Exhibit No.</span></b></td><td style="text-align: justify"><b><span style="text-decoration: underline">Description</span></b></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 1in"><b>99.1</b></td><td style="text-align: justify"><b><a href="radnet_ex9901.htm">Press Release dated November 9, 2020.</a></b></td></tr>                                                                                                                                                                                                                                                                                                                                                                                                                                                                     <tr style="vertical-align: top">
<td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td><b>99.2</b></td><td style="text-align: justify"><b><a href="radnet_ex9902.htm">Transcript of conference call.</a></b></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td>104</td><td style="text-align: justify">The cover page from this Current Report on Form 8-K, formatted in Inline XBRL</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LbObP+guHSriFBki3haXSXFrRtr580i+pXVDDIGQnPPlCDEQa1rpChnOizyDI9ZNpRxCjiUymgt6R7rZJuBnjldtHSvjuvUHpuQZ9MwkHCt/75x3bbFIQM6Go2gYS5DTRM7hsBPBV0/JlLpA47SqQJkCDkwNa3SKX/2Ho3qSofrVJZ2QrSaTQBTKXn5DLKMY9nRXD+KbhSxLRTDoKhBrprb5xrTWUQ3LCmufZXv038EH3+dJHQ== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>radnet_ex9901.htm
<DESCRIPTION>PRESS RELEASE DATED NOVEMBER 9, 2020
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">Exhibit 99.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="color: red"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR IMMEDIATE RELEASE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 12pt"><B>RadNet Reports Third Quarter
Financial Results Demonstrating Strong Recovery from the COVID-19 Impact</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Indicating a substantial recovery from the impact of COVID-19,
Total Net Revenue (&ldquo;Revenue&rdquo;) was $291.8 million in the third quarter of 2020, a sequential increase of 53.1% from
the second quarter of 2020 and a decrease of only 0.3% from last year&rsquo;s third quarter of $292.7 million</I></FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>As a result of aggressive cost containment measures, Adjusted EBITDA<SUP>(1)</SUP>
was $45.8 million in the third quarter of 2020, a sequential increase of 102.8% from the second quarter of 2020 and an increase
of 11.7% from last year&rsquo;s third quarter Adjusted EBITDA<SUP>(1)</SUP> of $41.0 million </I></FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Adjusted EBITDA<SUP>(1)</SUP> margin was 15.7% during the quarter
as compared to 14.0% in last year&rsquo;s third quarter, an increase of 169 basis points (1.7%)</I></FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Adjusting for the non-cash impact from the Company&rsquo;s interest
rate hedges on Net Income (&ldquo;Adjusted Net Income&rdquo;), Adjusted Net Income Per Share was $0.15 in this year&rsquo;s third
quarter, as compared to Adjusted Net Loss Per share of $(0.16) in the second quarter of this year and Net Income Per Share of $0.06
in last year&rsquo;s third quarter; this is a sequential increase of $0.31 per share from the second quarter of 2020 and $0.09
per share from last year&rsquo;s third quarter </I></FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Aggregate procedural volumes increased 66.2% from the second quarter
of 2020</I></FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>At third quarter end, RadNet had a cash balance of $89.7 million
and was undrawn on its $195 million revolving line of credit </I></FONT></TD></TR></TABLE>

<P STYLE="text-align: justify; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 0.25in"></TD><TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Subsequent to quarter end, RadNet announced the formation of a
joint venture with Adventist Health in Simi Valley, California and the creation of a new operating platform in Phoenix, Arizona
with Dignity Health/CommonSpirit Health</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0 0pt 0.25in; font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>LOS ANGELES, California, November 9,
2020 &ndash; RadNet, Inc. (NASDAQ: RDNT),</B> <FONT STYLE="color: black">a national leader in providing high-quality, cost-effective,
fixed-site outpatient diagnostic imaging services through a network of 334 owned and/or operated outpatient imaging centers</FONT>,
today reported financial results for its third quarter of 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger, President and Chief
Executive Officer of RadNet, commented, &ldquo;I am very pleased with our performance during the quarter. Our sequential improvement
from the second quarter of 2020 is illustrative of both a strong recovery of our procedural volumes and our focus on controlling
costs. Compared to the second quarter of this year, our Revenue grew 53.1% and our aggregate procedural volumes increased 66.2%.
Our Adjusted EBITDA increased 102.8% from the second quarter, and our Adjusted Net Income Per Share increased by $0.31, reversing
an Adjusted Net Loss Per Share in the second quarter of $(0.16). Our Adjusted EBITDA margin increased by 169 basis points (1.7%)
from last year&rsquo;s third quarter. The improvement in Adjusted EBITDA, Adjusted EBITDA margin and Net Income Per Share as compared
to the second quarter is even more notable since this year&rsquo;s second quarter results were aided by $25.5 million of funds
we received and recognized as income under the CARES Act Provider Relief Fund. This quarter, we received only $221,000 of Cares
Act funds.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Berger continued, &ldquo;COVID-19 necessitated
that we evaluate every part of our business to reduce expenses and conserve cash. In addition to staffing, we addressed costs associated
with purchasing, pre-authorization, scheduling, revenue cycle management, equipment service, facility rent, insurance and center-level
operating protocols. The adjustments we made over the last six months have materially improved how we are delivering our services
and have significantly increased operating margins. These enhancements should favorably contribute to our performance in the coming
quarters, as increasing procedural volumes are anticipated if our country continues to recover from COVID-19.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Berger added, &ldquo;During the COVID-19
period, we temporarily closed facilities, suspended certain modalities at some facilities which remained open, consolidated patient
volume into the centers of excellence, negotiated and restructured agreements with vendors and landlords and reduced employee costs
through furloughs and temporary salary cuts, among other actions. Not only did these actions prove to secure our business in this
difficult period, but they resulted in enhanced liquidity. We completed the third quarter with a cash balance of $89.7 million,
and we remain undrawn on our $195 million revolving line of credit. I am also pleased to report that, as of August 1<SUP>st</SUP>,
we began bringing back substantially all of our employees from furloughs and restored the wages of those team members who took
pay reductions as a result of COVID-19. This process was completed as of October 1<SUP>st</SUP>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;In October, we announced two partnerships
that should further our strategic growth. First, we partnered with Adventist Health to create an outpatient imaging joint venture
in Simi Valley, California to initially include three multimodality facilities and the management of the Nancy Reagan Breast Center.
This affiliation with Adventist Health, one of the largest health systems on the West Coast and Hawaii, is scheduled to begin operations
in January. Second, we created an operating platform in Phoenix, Arizona through a partnership with Dignity Health/CommonSpirit
Health. Though this is our third partnership with Dignity, it is RadNet&rsquo;s first entry into a new geography since we entered
the New York City marketplace in 2013. We initially acquired eight Arizona facilities and, with Dignity, are committed to substantially
growing the scope and breadth of this platform. Dignity will bring great value to the newly created partnership through its ownership
of hospitals, medical groups and urgent care centers and its broad affiliations and relationships with physician practices in the
Phoenix healthcare delivery system,&rdquo; concluded Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Third Quarter Financial Results</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the third quarter of 2020, RadNet reported
Revenue of $291.8 million, Adjusted EBITDA<SUP>(1)</SUP> of $45.8 million and Net Income of $6.2 million. Compared to the second
quarter of this year, Revenue increased $101.2 million (or 53.1%) and Adjusted EBITDA<SUP>(1)</SUP> increased $23.2 million (or
102.8%). Revenue decreased $916,000 (or 0.3%) and Adjusted EBITDA<SUP>(1)</SUP> increased $4.8 million (or 11.7%) from last year&rsquo;s
same quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net Income increased $3.0 million compared
to the third quarter of 2019 and increased $16.8 million from the second quarter of 2020. <FONT STYLE="color: black">Net Income
Per Share for the third quarter of 2020 was $0.12, compared to Net Income Per Share in the third quarter of 2019 of $0.06 (based
upon a weighted average number of diluted shares outstanding of 52.0 million in 2020 and 50.4 million in 2019). Adjusting for the
non-cash impact of the Company&rsquo;s interest rate hedges in this year&rsquo;s third quarter, Adjusted Net Income Per Share was
$0.15. This compares to Adjusted Net Loss Per Share of $(0.16) in the second quarter of 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: black">Affecting Net
Income in the third quarter of 2020 were certain non-cash expenses or non-recurring items including: $2.1 million of non-cash employee
stock compensation expense resulting from the vesting of certain options and restricted stock; </FONT>$571,000 of severance paid
in connection with headcount reductions related to cost savings initiatives; $342,000 loss on the sale or disposal of certain capital
equipment; $2.0 million of non-cash impact from interest rate hedges; and <FONT STYLE="color: black">$1.1 million of amortization
of deferred financing costs, other non-cash interest and loan discounts related to our credit facilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the third quarter of 2020, as compared
to the prior year&rsquo;s third quarter, MRI volume decreased 6.1%, CT volume was flat and PET/CT volume increased 0.4%. Overall
volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, decreased 5.7%
from the prior year&rsquo;s third quarter. On a same-center basis, including only those centers which were part of RadNet for both
the third quarters of 2020 and 2019, MRI volume decreased 5.8%, CT volume decreased 0.9% and PET/CT volume increased 2.3%. Overall
same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, decreased
5.6% compared to the prior year&rsquo;s same quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Nine Month Financial Results</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the nine months ended September 30,
2020, RadNet reported Revenue of $763.9 million, Adjusted EBITDA<SUP>(1)</SUP> of $88.8 million and Net Loss of $20.8 million.
Revenue decreased $89.4 million (or 10.5%), Adjusted EBITDA<SUP>(1)</SUP> decreased $28.5 million (or 24.3%) and Net Income decreased
$25.2 million from the first nine months of 2019. <FONT STYLE="color: black">Net Loss Per Share for the nine month period ended
September 30, 2020 was $(0.41), compared to Net Income Per Share of $0.09 in corresponding nine month period of 2019 (based upon
a weighted average number of fully diluted shares outstanding of 50.7 million in 2020 and 50.1 million in 2019). Adjusting for
the non-cash impact of the Company&rsquo;s interest rate hedges, Adjusted Net Loss Per Share was $(0.31) for the nine month period
of 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: black">Affecting operating
results in the </FONT>nine months ended September 30, 2020 <FONT STYLE="color: black">were certain non-cash expenses or non-recurring
items including: $10.1 million of non-cash employee stock compensation expense resulting from the vesting of certain options and
restricted stock; </FONT>$1.6 million of severance paid in connection with headcount reductions related to cost savings initiatives;
$543,000 loss on the sale or disposal of certain capital equipment; $6.7 million of non-cash impact from interest rate hedges;
and <FONT STYLE="color: black">$3.3 million of amortization of deferred financing costs, other non-cash interest and loan discounts
related to our credit facilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Conference Call for Today</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger, President and Chief
Executive Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call to discuss
its third quarter 2020 results on Monday, November 9th, 2020 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Conference Call Details:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: Monday, November 9, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Time: 10:30 a.m. Eastern Time</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dial In-Number: 866-248-8441</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">International Dial-In Number: 786-204-3966</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It is recommended that participants dial
in approximately 5 to 10 minutes prior to the start of the 10:30 a.m. call. There will also be simultaneous and archived webcasts
available at <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>http://public.viavid.com/index.php?id=142324</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">or http://www.radnet.com under the &ldquo;Investors&rdquo;
menu section and &ldquo;News Releases&rdquo; sub-menu of the website. An archived replay of the call will also be available and
can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 for international callers, and using the passcode 9769738.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>About RadNet, Inc.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">RadNet, Inc. is the leading national provider
of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging
revenue. RadNet has a network of 334 owned and/or operated outpatient imaging centers. RadNet's core markets include California,
Maryland, Delaware, New Jersey, New York and Arizona. In addition, RadNet provides radiology information technology solutions,
teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together
with affiliated radiologists, and inclusive of full-time and per diem employees and technicians, RadNet has a total of approximately
8,600 employees. For more information, visit http://www.radnet.com.</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Forward Looking Statements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">This press release contains &ldquo;forward-looking
statements&rdquo; within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.
Forward-looking statements are expressions of our current beliefs, expectations and assumptions regarding the future of our business,
future plans and strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can
generally be identified by words such as: &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;goal,&rdquo;
&ldquo;seek,&rdquo; &ldquo;believe,&rdquo; &ldquo;project,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;strategy,&rdquo;
&ldquo;future,&rdquo; &ldquo;likely,&rdquo; &ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;will&rdquo; and similar references
to future periods. Forward-looking statements in this press release include, among others, statements we make regarding response
to and the expected future impacts of COVID-19, including statements about our anticipated business results, balance sheet and
liquidity and our future liquidity, burn rate and our continuing ability to service or refinance our current indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">Forward-looking statements are neither
historical facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently
subject to uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our
control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements.
Therefore, you should not place undue reliance on any of these forward-looking statements. Important factors that could cause our
actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among
others, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the ongoing impact of the COVID-19 pandemic
on our business, suppliers, payors, customers, referral sources, partners, patients and employees, including (i) government&rsquo;s
unprecedented action regarding existing and potential restrictions and/or obligations related to citizen and business activity
to contain the virus; (ii) the consequences of an economic downturn resulting from the impacts of COVID-19 and the possibility
of a global economic recession; (iii) the impact of the volume of canceled or rescheduled procedures, whether as a result of government
action or patient choice; (iv) measures we are taking to respond to the COVID-19 pandemic, including changes to business practices;
(v) the impact of government and administrative regulation, guidance and appropriations; (vi) changes in our revenues due to declining
patient procedure volumes, changes in payor mix; (vii) potential increased expenses or workforce disruptions related to our employees
that could lead to unavailability of key personnel; (viii) workforce disruptions related to our key partners, suppliers, vendors
and others we do business with; (ix) the impact of return to work orders in certain states in which we operate; and (x) increased
credit and collectability risks;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the availability and terms of capital
to fund our business;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our ability to service our indebtedness,
make principal and interest payments as those payments become due and remain in compliance with applicable debt covenants, in addition
to our ability to refinance such indebtedness on acceptable terms;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in general economic conditions
nationally and regionally in the markets in which we operate;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the availability and terms of capital
to fund the expansion of our business and improvements to our existing facilities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our ability to maintain our current credit
rating and the impact on our funding costs and competitive position if we do not do so;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">volatility in interest and exchange rates,
or credit markets;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the adequacy of our cash flow and earnings
to fund our current and future operations;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in service mix, revenue mix and
procedure volumes; </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">delays in receiving payments for services
provided;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">increased bankruptcies among our partner
physicians or joint venture partners;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the impact of the political environment
and related developments on the current healthcare marketplace and on our business, including with respect to the future of the
Affordable Care Act; </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the extent to which the ongoing implementation
of healthcare reform, or changes in or new legislation, regulations or guidance, enforcement thereof by federal and state regulators
or related litigation result in a reduction in coverage or reimbursement rates for our services, or other material impacts to our
business;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">closures or slowdowns and changes in labor
costs and labor difficulties, including stoppages affecting either our operations or our suppliers' abilities to deliver supplies
needed in our facilities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the occurrence of hostilities, political
instability or catastrophic events; </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the emergence or reemergence of and effects
related to future pandemics, epidemics and infectious diseases; and </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">noncompliance by us with any privacy or
security laws or any cybersecurity incident or other security breach by us or a third party involving the misappropriation, loss
or other unauthorized use or disclosure of confidential information.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any forward-looking statement contained
in this current report is based on information currently available to us and speaks only as of the date on which it is made. We
undertake no obligation to publicly update any forward-looking statement, whether written or oral, that we may make from time to
time, whether as a result of changed circumstances, new information, future developments or otherwise, except as required by applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Regulation G: GAAP and Non-GAAP Financial
Information</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This release contains certain financial
information not reported in accordance with GAAP. The Company uses both GAAP and non-GAAP metrics to measure its financial results.
The Company believes that, in addition to GAAP metrics, these non-GAAP metrics assist the Company in measuring its cash-based performance.
The Company believes this information is useful to investors and other interested parties because it removes unusual and nonrecurring
charges that occur in the affected period and provides a basis for measuring the Company's financial condition against other quarters.
Such information should not be considered as a substitute for any measures calculated in accordance with GAAP, and may not be comparable
to other similarly titled measures of other companies. Non-GAAP financial measures should not be considered in isolation from,
or as a substitute for, financial information prepared in accordance with GAAP. Reconciliation of this information to the most
comparable GAAP measures is included in this release in the tables which follow.</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>CONTACTS: </I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>RadNet, Inc.</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Mark Stolper, 310-445-2800</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Executive Vice President and Chief
Financial Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: left; background-color: white">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED BALANCE SHEETS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">September 30, 2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">December 31, 2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: center">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">CURRENT ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 70%; text-align: left; text-indent: -10pt; padding-left: 20pt">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">89,739</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">40,165</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">137,411</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">154,763</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Due from affiliates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">424</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,242</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">31,482</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">45,004</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 40pt">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">259,056</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">241,174</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">361,950</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">367,795</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Operating lease right-of-use assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">451,613</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">445,477</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 40pt">Total property, equipment and right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">813,563</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">813,272</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">OTHER ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">470,685</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">441,973</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Other intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57,152</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,994</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Deferred financing costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,944</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,559</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Investment in joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,571</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,470</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Deferred tax assets, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,188</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,548</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Deposits and other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">37,707</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">36,996</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 40pt">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,717,866</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,646,986</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: center">LIABILITIES AND EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">CURRENT LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Accounts payable, accrued expenses and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">205,701</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">207,585</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Due to affiliates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,287</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,347</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">45,846</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,316</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Current finance lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,041</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,283</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Current operating lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67,449</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">61,206</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Current portion of notes payable</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">39,463</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">39,691</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 40pt">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">373,787</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">327,428</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">LONG-TERM LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Long-term finance lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,108</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,264</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Long-term operating lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">428,233</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">420,922</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Notes payable, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">627,179</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">652,704</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Other non-current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">41,438</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,529</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 40pt">Total liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,471,745</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,413,847</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Common stock - $.0001 par value, 200,000,000 shares authorized; 51,596,098 and 50,314,328 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Additional paid-in-capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">306,079</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">262,865</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Accumulated other comprehensive loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(24,923</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,026</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(123,956</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(103,159</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 40pt">Total RadNet, Inc.'s stockholders' equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">157,205</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">151,685</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">88,916</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">81,454</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 40pt">Total equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">246,121</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">233,139</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 40pt">Total liabilities and equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,717,866</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,646,986</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(unaudited)</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Three Months Ended September 30,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Nine Months Ended September 30,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="text-align: center; padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">REVENUE</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 40%; text-align: left; text-indent: -10pt; padding-left: 20pt">Service fee revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">256,730</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">261,908</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">660,760</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">762,751</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Revenue under capitation arrangements</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">35,046</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">30,784</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">103,145</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">90,587</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 40pt">Total service revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">291,776</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">292,692</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">763,905</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">853,338</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Provider relief funding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">221</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,696</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">OPERATING EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Cost of operations, excluding depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">246,462</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">254,383</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">708,095</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">743,997</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,247</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,490</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">64,536</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,193</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Loss on sale and disposal of equipment and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">342</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">917</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">543</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,990</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Severance costs</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">571</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">52</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,647</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,054</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 40pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">268,622</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">275,842</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">774,821</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">807,234</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">INCOME FROM OPERATIONS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,375</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,850</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,780</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">46,104</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">OTHER INCOME AND EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,061</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,895</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,443</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,589</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Equity in earnings of joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,276</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,955</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,176</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,072</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Non-cash change in fair value of interest rate hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">679</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,523</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Other (income) expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(139</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(247</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,271</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 40pt">Total other expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,325</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,942</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">32,543</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">31,788</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">INCOME (LOSS) BEFORE INCOME TAXES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,050</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,908</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(17,763</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,316</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">(Provision for) benefit from income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,825</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,816</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,029</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,556</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">NET INCOME (LOSS)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,225</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,092</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,734</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,760</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Net income attributable to noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,069</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,897</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,063</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,400</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,156</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,195</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(20,797</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">4,360</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.12</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.06</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.41</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.09</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.12</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.06</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.41</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.09</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Basic</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">51,358,603</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">49,807,460</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">50,746,380</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">49,597,138</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">51,955,815</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">50,360,360</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">50,746,380</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">50,113,306</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(unaudited)</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Nine Months Ended September 30,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 70%; text-align: left; text-indent: -10pt; padding-left: 20pt">Net (loss) income</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">(12,734</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">10,760</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Adjustments to reconcile net (loss) income to net cash provided by operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">64,536</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,193</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Amortization of operating lease assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,769</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,948</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Equity in earnings of joint ventures,net of dividends</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">530</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,148</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Amortization deferred financing costs and loan discount</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,266</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,103</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Loss on sale and disposal of equipment and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">543</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,990</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Amortization of cash flow hedge, net of taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,861</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Non-cash change in fair value of interest rate hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,523</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Stock-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,144</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,963</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Other noncash item included in cost of operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(559</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Change in fair value of contingent consideration</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(145</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,749</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,380</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,467</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Other current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,522</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,569</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Other assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(700</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,770</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Deferred taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,640</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,230</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Operating leases</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(43,351</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(49,721</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 30pt">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,530</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(490</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Accounts payable, accrued expenses and other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">23,309</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">19,349</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 40pt">Net cash provided by operating activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">170,343</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">82,603</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Purchase of imaging facilities and other acquisitions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,125</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(27,150</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Equity investments at fair value</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(143</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Purchase of property and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(77,303</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(68,269</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from sale of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">779</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">760</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from sale of equity interests in a joint venture</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">132</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Nulogix return of capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">792</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Equity contributions in existing joint ventures</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,631</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(103</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 40pt">Net cash used in investing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(88,280</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(93,981</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Principal payments on notes and leases payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,704</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,778</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Payments on Term Loan Debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(32,472</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(29,918</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Additional deferred finance costs on revolving loan amendment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(741</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from issuance of new debt, net of issuing costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">97,144</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from Payment Protection Program</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,023</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Distributions paid to noncontrolling interests</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(601</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,818</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from sale of noncontrolling interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,275</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Contribution from a noncontrolling partners</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">750</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Proceeds from revolving credit facility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">250,900</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">251,200</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Payments on revolving credit facility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(250,900</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(279,200</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Proceeds from issuance of common stock upon exercise of options</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">50</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 30pt">Net cash (used in) provided by financing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(32,495</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">38,705</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">EFFECT OF EXCHANGE RATE CHANGES ON CASH</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(28</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">NET INCREASE IN CASH AND CASH EQUIVALENTS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,574</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">27,299</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">CASH AND CASH EQUIVALENTS, beginning of period</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">40,165</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">10,389</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">CASH AND CASH EQUIVALENTS, end of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">89,739</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">37,688</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 20pt">Cash paid during the period for interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">31,210</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">36,058</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center; background-color: white"><B>RADNET,
INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center; background-color: white"><B>RECONCILIATION
OF GAAP NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.95pt 0pt 0; text-align: center; background-color: white"><B>COMMON SHAREHOLDERS TO ADJUSTED EBITDA<SUP>(1)</SUP></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.25in; text-align: center; background-color: white"><B>(IN THOUSANDS)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><BR STYLE="clear: both"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center">Three Months Ended</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1pt solid">September 30,</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 70%; text-align: left; text-indent: -10pt; padding-left: 10pt">Net Income Attributable to RadNet, Inc. Common Shareholders</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">6,156</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">3,195</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Interest Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,061</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,895</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Provision for Income Taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,825</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,816</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Depreciation and Amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,247</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,490</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Loss on Sale of Equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">342</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">917</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Severance Costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">571</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Plus Non-cash Change in Fair Value of Interest Rate Hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">679</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Plus Other (Gains) Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(139</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Plus Non-Cash Employee Stock-Based Compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,067</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,381</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Plus Legal Settlements</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,248</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; font-style: normal; padding-bottom: 2.5pt; padding-left: 20pt"><B>Adjusted EBITDA<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><SUP>(1)</SUP></FONT></B></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">45,809</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">40,996</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center">Nine Months Ended</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1pt solid">September 30,</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 70%; text-align: left; text-indent: -10pt; padding-left: 10pt">Net (Loss) Income Attributable to RadNet, Inc. Common Shareholders</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">(20,797</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">4,360</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Interest Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,443</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,589</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Plus (Benefit From) Provision for Income Taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,029</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,557</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Depreciation and Amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">64,536</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,193</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Loss on Sale of Equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">543</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,989</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Severance Costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,647</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,054</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Plus Non-cash Change in Fair Value of Interest Rate Hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,523</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Other (Gains) Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(247</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,271</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; text-indent: -10pt; padding-left: 10pt">Plus Non-Cash Employee Stock-Based Compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,144</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,964</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Plus Legal Settlements</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,248</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; font-style: normal; padding-bottom: 2.5pt; padding-left: 20pt"><B>Adjusted EBITDA<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal"><SUP>(1)</SUP></FONT></B></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">88,763</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">117,225</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Footnotes</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: windowtext"><SUP>(1)</SUP>
The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, each from continuing operations
and adjusted for losses or gains on the sale of equipment, other income or loss, transaction expenses, debt extinguishments and
non-cash equity compensation. Adjusted EBITDA</FONT> includes equity earnings in unconsolidated operations and subtracts allocations
of earnings to non-controlling interests in subsidiaries<FONT STYLE="color: windowtext">, and is adjusted for non-cash or extraordinary
and one-time events taken place during the period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted EBITDA is reconciled to its nearest
comparable GAAP financial measure. Adjusted EBITDA is a non-GAAP financial measure used as analytical indicator by RadNet management
and the healthcare industry to assess business performance, and is a measure of leverage capacity and ability to service debt.
Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA
should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing
activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance
or liquidity. As Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying
methods of calculation, this metric, as presented, may not be comparable to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">PAYOR CLASS BREAKDOWN</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp; &nbsp;
&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Third Quarter</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 45%; text-align: left">Commercial Insurance/Other Patient Revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">57.9</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Medicare</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21.5</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Capitation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.0</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Workers Compensation/Personal Injury</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.5</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Medicaid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.4</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Other/Non Patient</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3.7</TD><TD STYLE="padding-bottom: 1pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET PAYMENTS
BY MODALITY</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Third Quarter</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Full Year</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Full Year</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Full Year</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2018</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2017</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 40%">MRI</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">35.1</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">35.8</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">35.2</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">34.9</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>CT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.3</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.9</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.5</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.2</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>PET/CT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.8</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.6</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.7</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.2</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>X-ray</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.2</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.4</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.9</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Ultrasound</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.4</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.4</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.2</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.1</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Mammography</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.5</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.2</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.8</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.3</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Nuclear Medicine</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.9</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.1</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.1</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.7</TD><TD STYLE="padding-bottom: 1pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.9</TD><TD STYLE="padding-bottom: 1pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5.1</TD><TD STYLE="padding-bottom: 1pt; text-align: left">%</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5.2</TD><TD STYLE="padding-bottom: 1pt; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>radnet_ex9902.htm
<DESCRIPTION>TRANSCRIPT OF CONFERENCE CALL
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">Exhibit 99.2</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>C O R P O R A T E P
A R T I C I P A N T S</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper, </B><I>Executive Vice
President and Chief Financial Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger, </B><I>Chairman,
President and Chief Executive Officer</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>C O N F E R E N C E
C A L L P A R T I C I P A N T S</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut, </B><I>Jefferies</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal, </B><I>Sidoti &amp;
Co. LLC</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>John Ransom, </B><I>Raymond James</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00339A"><B>P R E S E N T A T I
O N</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good day, and welcome to the RadNet Inc.
Third Quarter 2020 Financial Results Call. Today&rsquo;s conference is being recorded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I would like to turn the
conference over to Mr. Mark Stolper, Executive Vice President and Chief Financial Officer of RadNet. Please go ahead, sir.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. Good morning, ladies and gentlemen,
and thank you for joining Dr. Howard Berger and me today to discuss RadNet&rsquo;s Third Quarter 2020 Financial Results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before we begin today, we&rsquo;d like
to remind everyone of the Safe Harbor statement under the Private Securities Litigation Reform Act of 1995. This presentation contains
forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements
concerning anticipated future financial and operating performance and liquidity, our response to and the expected future impact
of COVID-19, our ability to stabilize and continue to grow the business by generating patient referrals and contracts with radiology
practices, recruiting and retaining technologists, consummating acquisitions and joint ventures, receiving third-party reimbursement
for diagnostic imaging services, successfully integrating acquired operations, generating revenue and Adjusted EBITDA for the acquired
operations as estimated, among others, are forward-looking statements within the meaning of the Safe Harbor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Forward-looking statements are based on
Management&rsquo;s current preliminary expectations and are subject to risks and uncertainties which may cause RadNet&rsquo;s actual
results to differ materially from the statements contained herein. These risks and uncertainties include those risks set forth
in RadNet&rsquo;s reports filed with the SEC from time to time, including RadNet&rsquo;s Annual Report on Form 10-K for the year
ended December 31, 2019, and our Quarterly Report on Form 10-Q, to be filed shortly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Undue reliance should not be placed on
forward-looking statements, especially guidance on future financial performance, which speaks only as of the date it is made. RadNet
undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances
after the date they were made, or to reflect the occurrence of unanticipated events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that, I&rsquo;d like to turn the call
over to Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Mark. Good morning, everyone,
and thank you for joining us today.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On today&rsquo;s call, Mark and I plan
to provide you with highlights from our third quarter 2020 results, give you more insight into factors which affected this performance,
discuss in some detail the progress we made during this COVID-19 period, and give details of our future strategy. After our prepared
remarks, we will open the call to your questions. I&rsquo;d like to thank all of you for your interest in our Company and for dedicating
a portion of your day to participate in our conference call this morning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before we start, I would like to say, on
behalf of myself and the entire team at RadNet, we hope all of you and your loved ones are healthy and staying safe. We are extremely
grateful for all of our stakeholders, including our employees, business partners, lenders and shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Let&rsquo;s begin.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;m very pleased with the performance
of our business in the third quarter. Our significantly improved revenue and profitability, relative to the second quarter, is
the result of recovery in procedural volumes and the multitude of cost savings and cash conservation measures we instituted throughout
the COVID-19 period. Our revenue increased 53.1% sequentially from the second quarter, with a procedural volume increase of 66.2%,
driving this top line performance. This was an increase of $101.2 million in revenue from the second quarter&rsquo;s results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Perhaps even more notable is our improvement
in Adjusted EBITDA and earnings. Our Adjusted EBITDA more than doubled from the second quarter, increasing from $22.6 million to
$45.8 million. This difference would have been greater had we not recognized $25.5 million of CARES Act funds in the second quarter.
By comparison, we recorded only $221,000 of CARES Act funds in the third quarter. As compared to the third quarter of last year,
despite our revenue being essentially flat, our Adjusted EBITDA increased from $41.0 million to $45.8 million, or 11.7%. This resulted
in Adjusted EBITDA margins increasing from 14% in last year&rsquo;s third quarter to 15.7%. Because many of the COVID-19 cost reduction
initiatives which drove the improvement in margins are ongoing and not one-time, we have the opportunity for sustained margin improvement
in future quarters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted net income per share was $0.15
this year&rsquo;s third quarter, as compared to Adjusted net loss per share of $0.16 in the second quarter of this year, and net
income per share of $0.06 in last year&rsquo;s third quarter. This is a sequential increase of $0.31 per share from the second
quarter of 2020, and $0.09 per share from last year&rsquo;s third quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the increase in our procedural
volumes throughout the third quarter, a strong liquidity position and a cautiously optimistic belief that procedural volumes will
continue to recover, I am pleased to report that as of August 1 we began bringing back substantially all of our employees from
furloughs and restored the wages of those team members who took pay reductions as a result of COVID-19. We completed this process
on October 1. I want to thank all of our team members for their patience and commitment during this difficult period. Our frontline
imaging center employees continue to be the true heroes, ensuring access to care in a safe environment for the benefit of our referring
physicians and patient communities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently, we have reopened all but 19
imaging centers, the majority of which are routine imaging satellite locations, designed to alleviate the traffic in our larger,
more advanced multimodality facilities. As procedural volumes continue to recover, we&rsquo;ll hopefully move beyond the&mdash;and
move beyond the COVID-19 period, we will re-evaluate opening facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The coronavirus pandemic allowed us a unique
opportunity to focus on all aspects of our business, including center level back office and administrative operations, to create
efficiencies and reduce costs. Prior to COVID-19, we spent several years significantly increasing the scope and breadth of our
business through organic growth and acquisitions. While this expansion has been beneficial to our business in virtually every market
in which we operate, COVID-19 allowed us to focus on ways to most effectively reduce expenses and conserve cash at a time when
growth was not a priority. This optimization process over the last six months has brought great value to RadNet, value that not
only was demonstrated in the third quarter, but that will continue to pay dividends into the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The cost and liquidity saving measures,
along with increasing procedural volumes, CARES Act funds and Medicare advances, resulted in an $89.7 million cash balance at quarter
end and our being undrawn on our $195 million revolving credit facility. This is the strongest liquidity position in the Company&rsquo;s
history.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;d like to also recognize the support
we receive from our relationship banks. At the end of August, we completed a $57.5 million upsize of our revolving credit facility.
While our cash balance continues to be strong, the additional capacity provides us further financial flexibility to grow our business
and execute our strategic plan. Along with our increased liquidity and improved financial results, our leverage declined by over
a quarter of a turn in the quarter to under 4.25 times net debt to EBITDA. We expect that our leverage will return to under 4 times
net debt to EBITDA in the coming quarters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Throughout the COVID period, our capitation
business has remained an important feature of RadNet. Our capitation revenue increased 15.8% from the third quarter of last year.
Because we get paid a fixed capitated amount per enrollee managed by the medical groups with whom we contract, our capitation revenue
and the associated cash flow is dependent upon enrollment in these health plans. Throughout COVID-19, enrollment for these HMO
patients with our contracted medical groups has remained intact, as patients and their employees, even for those who have been
furloughed, have continued to pay healthcare premiums.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequent to the end of the third quarter,
we announced a new partnership with Adventist Health, one of the largest health systems on the West Coast and Hawaii, to create
an outpatient imaging joint venture in Simi Valley, California. Under the new joint venture, RadNet will contribute two of its
Simi Valley imaging centers, Alamo Advanced Imaging and Simi Valley Advanced Imaging, and Adventist Health will contribute its
Aspen Imaging Center. RadNet will also assume the operational management of Adventist Health&rsquo;s Nancy Reagan Breast Center.
Adventist Health&rsquo;s assets in Simi Valley include the ownership of a leading hospital, an urgent care center, a clinical laboratory,
homecare services, and various family and specialty physician practices. The partnership is scheduled to begin operations in January.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Two weeks ago, we announced the creation
of a new operating platform in Phoenix, Arizona, through a partnership with Dignity Health/CommonSpirit Health. While this is our
third venture with Dignity Health, this is RadNet&rsquo;s first entrance into a new geography since 2013, when we entered New York
City. In conjunction with establishing the partnership, we completed the acquisition of AZ Tech MRI &amp; Radiology, an eighth
location multimodality radiology practice in Phoenix. We are extremely excited about this strategic expansion into Arizona. Phoenix,
in particular, is a revenue-growing market and is home to almost 5 million people.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the venture, RadNet and Dignity will
develop a network of multimodality outpatient centers, expanding the geographic coverage of the acquired locations through a combination
of new site development and acquisition of existing radiology practices. Dignity Health is a leading health system in Phoenix and
owns and operates multiple hospitals, medical groups, specialty care locations in this marketplace, from which we can leverage
our operations. Our focus will be to aggressively expand our footprint in order to grow effectively, service the Dignity owned
and affiliated physician groups, and capture other patient volumes from competitive outpatient operators. We are committed to developing
significant management focus and financial resources to drive the density and geographic concentration in Phoenix, that has made
it successful in our other core markets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I&rsquo;d like to turn the
call back over to Mark to discuss some of the highlights of our third quarter 2020 performance. When he is finished, I will make
some closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Howard.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;m now going to briefly review our
third quarter 2020 performance and attempt to highlight what I believe to be some material items. I will also give some further
explanation of certain items in our financial statements, as well as provide some insights into some of the metrics that drove
our third quarter 2020 performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In my discussion, I will use the term Adjusted
EBITDA, which is a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation
and amortization, and excludes losses or gains on the disposal of equipment, other income or loss, loss on debt extinguishments
and non-cash equity compensation. Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations
of earnings to non-controlling interests in subsidiaries, and is adjusted for non-cash or extraordinary and one-time events taking
place during the period. A full quantitative reconciliation of Adjusted EBITDA to net income or loss attributable to RadNet, Inc.
common shareholders is included in our earnings release and our current report on Form 8-K, filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that said, I&rsquo;d now like to review
our third quarter results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the third quarter of 2020, RadNet reported
revenue of $291.8 million and Adjusted EBITDA of $45.8 million. As Dr. Berger discussed in his remarks, this performance was a
significant improvement from these metrics in the second quarter and is reflective as a major recovery of our business from the
impacts of COVID-19. Compared to the second quarter of this year, revenue increased $101.2 million, or 53.1%, and Adjusted EBITDA
increased $23.2 million, or 102.8%. Relative to last year&rsquo;s third quarter, a quarter that was not impacted by COVID-19, revenue
decreased only by $916,000, or 0.3%, and Adjusted EBITDA increased $4.8 million, or 11.7%. Our Adjusted EBITDA margin increased
385 basis points, or 3.9%, from the second quarter of 2020, and exceeded last year&rsquo;s third quarter by 169 basis points, or
1.7%. The increase in Adjusted EBITDA and Adjusted EBITDA margin, relative to last year&rsquo;s third quarter, is primarily the
result of the cost savings measures we took during COVID-19, many of which should aid our business into the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the third quarter of 2020, as compared
to the prior year&rsquo;s third quarter, MRI volume decreased 6.1%, CT volume was flat and PET/CT volume increased 0.4%. Overall
volume, taking into account routine imaging exams, inclusive of X-ray, ultrasound, mammography and all other exams, decreased 5.7%
from the prior year&rsquo;s third quarter. On a same-center basis, including only those centers which were part of RadNet for both
the third quarters of 2020 and 2019, MRI volume decreased 5.8%, CT volume decreased 0.9% and PET/CT volume increased 2.3%. Overall
same-center volume, taking into account all routine imaging exams, decreased 5.6%, compared to the prior year&rsquo;s same quarter.
Relative to the second quarter of this year, aggregate procedural volumes, inclusive of all modalities, increased 66.2%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the third quarter of 2020, we performed
1,890,156 total procedures. The procedures were consistent with our multimodality approach, whereby 76.5% of all the work we did
by volume was from routine imaging. Our procedures in the third quarter of 2020 were as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please note that the CT volumes for last
year have been restated to account for a change we made as of January 1 of this year in how we account for one of our CT CPT codes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The comparative numbers that follow are
on an apples-to-apples basis: 266,049 MRIs, as compared with 283,221 MRIs in the third quarter of 2019; 167,005 CTs, as compared
with 167,078 CTs in the third quarter of 2019; 10,886 PET/CTs, as compared with 10,847 PET/CTs in the third quarter of 2019; and
1,446,216 routine imaging exams, which include nuclear medicine, ultrasound, mammography, x-ray and all other exams, as compared
with 1,544,026 of all these exams in the third quarter of 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the third quarter, RadNet reported
net income attributable to RadNet, Inc. common shareholders of $6.2 million, an increase of approximately $3 million from the third
quarter of 2019. Sequentially, relative to the second quarter of this year, net income increased $16.8 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net income per share for the third quarter
of 2020 was $0.12, compared to net income per share in the third quarter of 2019 of $0.06, based upon weighted average number of
diluted shares outstanding of 52 million shares in 2020, and 50.4 million shares in 2019. Adjusting for the non-cash impact of
the Company&rsquo;s interest rate hedges in this year&rsquo;s third quarter, adjusted net income was $0.15 per share. This compares
to adjusted net loss per share of negative $0.16 in the second quarter of 2020. Affecting net income in the third quarter of 2020
were certain non-cash expenses or non-recurring items, including the following: $2.1 million of non-cash employee stock compensation
expense resulting from the vesting of certain options and restricted stock, $571,000 of severance paid in connection with headcount
reductions related to cost savings initiatives, a $342,000 loss on the sale or disposal of certain capital equipment, $2 million
of non-cash impact from interest rate hedges, and $1.1 million of amortization of deferred financing costs and non-cash interest
on loan discounts related to our credit facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Overall, GAAP interest expense for the
third quarter of 2020 was $11.1 million. This compares with GAAP interest expense in the third quarter of 2019 of $11.9 million.
Cash paid for interest during the period, which excludes non-cash deferred financing expense and accrued interest, was $8.4 million,
as compared with $12.8 million in the third quarter of last year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With regards to our balance sheet, as of
September 30, 2020, unadjusted for bond and term loan discounts, we had $591.7 million of net debt, which is our total debt at
par value less our cash balance. Note that this debt balance includes New Jersey Imaging Network&rsquo;s debt of approximately
$54.5 million, for which RadNet is neither a borrower nor guarantor. This compares with $687.3 million of net debt at September
30, 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2020, we were undrawn
on our $195 million revolving line of credit and had a cash balance of $89.7 million. As Dr. Berger mentioned in his prepared remarks,
we upsized our revolver commitment with our relationship banks by $57.5 million in August of this year. While we have not needed
to access this liquidity, the larger revolver provides us additional operating flexibility and funds available for future growth,
should we require it.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At September 30, 2020, our accounts receivable
balance was $137.4 million, a decrease of $17.4 million from year end 2019. The decrease in accounts receivable is mainly the result
of the decline in our procedural volumes and revenue during the COVID-19 period and our significant cash collections on previously
existing accounts receivable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our day sales outstanding, or DSO, was
39.2 days at September 30, 2020, lower by approximately 5.4 days as of year end of 2019. The lower DSO is primarily a function
of a return to more normalized revenue during the last two months of the third quarter. As revenue in accounts receivable normalizes
post-COVID-19, we expect DSOs to return to the low- to mid-40s level.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Through September 30, 2020, we had total
capital expenditures, net of asset dispositions, of $71.8 million. This includes $5.5 million of capital expenditures of New Jersey
Imaging Network, our joint venture with RWJ Barnabas.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;ll now take a few minutes to give
you an update on 2021 reimbursement and discuss what we know with regards to 2021 anticipated Medicare rates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As some of you may recall from our second
quarter financial results call, with respect to Medicare reimbursement, we&rsquo;ve received a matrix for proposed rates by CPT
code in August, which is typically part of the physician fee schedule proposal that is released about that time every year. We&rsquo;ve
completed an initial analysis and compared those rates to 2020 rates. We volume-weighted our analysis using expected 2021 procedural
volumes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">CMS moved forward with an increased reimbursement
for evaluation and management of CPT codes which favor certain physician specialties that regularly bill for these services, particularly
primary care doctors. CMS proposed doing so with budget neutrality; meaning, that it proposed to reallocate reimbursement from
physicians who rarely bill for E&amp;M codes, such as radiologists, to physicians who regularly bill for these codes, such as primary
care physicians. In the proposed rule, CMS initiated a 10.6% decrease in the conversion factor used to calculate Medicare reimbursement
for all specialties in 2021. For radiology, CMS made a material upward adjustment to the technical RVUs in the reimbursement formula.
These RVUs are multiplied by this now lower conversion factor to determine our reimbursement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our initial analysis of these opposing
forces show that RadNet will suffer an approximately $11 million revenue hit in 2021 from our Medicare book of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are many lobbying groups from the
various medical specialties aggressively opposing the budget neutrality aspect of the E&amp;M code reimbursement changes, including
radiology&rsquo;s two main lobbying forces, the Association for Quality Imaging, or AQI, and the American College of Radiology,
or ACR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Late last month, U.S. Representatives Bera,
a Democrat from California, and Bucshon, a Republican from Indiana, introduced bipartisan legislation to provide relief to physicians
responding to the COVID-19 pandemic who are scheduled to receive these Medicare payment cuts next year. The bill would provide
a temporary additional payment in the amount of the difference between 2020 and 2021 Medicare reimbursement for two years for the
specialties, like radiology, that are facing the Medicare cut.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We should know more in December when the
final rules are released and when it is determined if the Bera/Bucshon bill will be attached to federal funding bills expected
to be put in place in mid-December.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I&rsquo;d now like to turn the call back
to Dr. Berger, who will make some closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Mark.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The coronavirus pandemic has allowed us
to take a pause from the rapid growth path we have followed over the last several years and evaluate all aspects of our business.
The efficiencies we created during this period position our operations for a strong performance in 2021. Furthermore, we enter
2021 with the strongest liquidity position in the Company&rsquo;s history.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Besides continuing to drive growth and
efficiency in our core imaging center business, we will further pursue ancillary opportunities to drive revenue, increase margins
and reduce costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For example, this year we installed our
first installation of the TULSA-PRO system, an incision-free, thermal ultrasound system designed to treat prostate disease. We
have begun to see patients at one of our Los Angeles area locations and are eager to expand this business as this new procedure
is adopted and continues to drive demand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Another ancillary opportunity we have been
aggressively pursuing is our commitment to artificial intelligence. In the second quarter of this year, we completed the acquisition
of DeepHealth, which has become the cornerstone of our artificial intelligence strategy. We are on track to submit for our first
approval to the Federal Drug Administration DeepHealth&rsquo;s first mammography product by end of the year. We hope to be utilizing
DeepHealth&rsquo;s first AI product in our workflow in the second half of next year, which we believe will enable our radiologists
to be more accurate and efficient.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As we move into 2021, health system joint
ventures will be another ancillary opportunity for growth. Currently, over 25% of our facilities are jointly owned with community
hospitals and large health systems, and, with the Dignity partnership in Phoenix, we have demonstrated our willingness to enter
new geographic markets in conjunction with entrenched partners. These partnerships, on average, drive higher margins that our wholly-owned
centers and assist us in securing fair, long-term pricing with regional payors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the third quarter, we announced a multifaceted
collaboration agreement with Hologic, focused on improving women&rsquo;s health. Hologic will contribute capabilities and insights
behind its market-leading hardware and software, and we will share data with Hologic produced by our fleet of high-resolution mammography
systems, the largest in the nation. The data will be used to train and refine current and future products based on artificial intelligence.
Both companies will work together to enable new joint market opportunities and further efforts to build clinician confidence and
develop and integrate new artificial intelligence technologies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In conclusion, even in this challenging
time, we continue to be very optimistic about the future of RadNet. We expect to emerge from COVID as the best positioned company
in our industry and we are excited to keep you apprised of our progress in the coming quarters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operator, we are now ready for the question
and answer portion of the call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, sir. If you&rsquo;d like to
ask a question, please signal by pressing star, one on your telephone keypad. If you are using a speakerphone, please make sure
that your mute function is turned off to allow your signal to reach our equipment. Once again, that is star, one if you&rsquo;d
like to ask a question. We will pause for just a moment to allow everyone an opportunity to signal. Again, that is star, one.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We&rsquo;ll take our first question from
Brian Tanquilut with Jefferies. Please go ahead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hey, good morning, guys. Congrats on a
solid quarter. I guess, Mark, my first question, just to follow up on your comments on the Medicare rules, do you mind just reminding
us how you&rsquo;re thinking about the impact on your P&amp;L if the proposed rule goes through as it is? Then, I think you talked
about timing. How do they think, or how do you guys think they&rsquo;re going to implement a one/one cut if we haven&rsquo;t had
any rules set out yet and we&rsquo;re already deep into November?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sure. Thank you, Brian. The conversion
factor is declining from $36.09 to $32.26, which is a 10.6% decrease. So, to the extent that the RVUs were to stay the same per
CPT code in radiology, all radiology providers would be facing a 10.6% decline in their reimbursement, but that&rsquo;s not what
Medicare did. Essentially, what Medicare did is they&mdash;the RVU calculation, as you&rsquo;re aware, consists of a technical
portion of the RVU and a professional portion of the RVU.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the professional portion of the RVU,
they either&mdash;depending upon the modality and the CPT code, they either kept it the same or they actually, on average, decreased
the professional RVUs to the tune of 1.2%. So, most of the professional-only models, such as hospital-based radiologists, next
year, if the proposed cut goes into place, are facing, really, an 11% to 12% hit on the various CPT codes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">But, for the technical RVUs, they actually
increased the technical RVUs across the board. I&rsquo;ll give you a couple examples. For instance, x-rays are our largest procedure
by volume, and our two most common x-ray procedures are a two-view chest x-ray and then the x-ray of the spine, lumbosacral, which
is a four-view x-ray, and the technical RVUs are going up for each of those by 8.7% and 10.3%, respectively. So, the increase in
the technical RVUs is partially mitigating the decrease in the conversion factor, and that&rsquo;s happened across the board. For
instance, in CT, our most CPT codes is the CT of the abdomen and the pelvis, and the technical&mdash;or the global RVUs of that
is going up by 7.3%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You can see what they&rsquo;ve tried to
do for imaging centers after eight years&mdash;and you&rsquo;re aware of this&mdash;of decreasing the technical RVUs, from 2007
to 2014, and not changing the professional RVUs. What they&rsquo;re doing now is, essentially, adjusting the professional component.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Where we are seeing the cut&mdash;and our
cut across the board, it comes out to about 5%, which equals that $11 million or so number that I talked about. Where we are going
to be seeing a cut, if the proposal goes into place as proposed, would be in mammo, where the global RVUs&mdash;the technical side
of the RVUs really is not changing, so we&rsquo;re going to see a full 10% cut there. So, it really depends upon your CPT code
mix, and when we did our analysis for 2021, we weighted it by our actual CPT code mix, or expected CPT code mix for 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to this Bera/Bocshon bill
that&rsquo;s out there, what it is proposing to do is, essentially, make up the difference between 2020 and 2021 with an additional
payment to providers. The proposal, I think because of COVID-19, the final rule isn&rsquo;t now supposed to come out until December
1, and this Bera/Bocshon bill, if it goes into place, would be part of an overall government spending bill that I think needs to
be passed, I think by December 11, if I remember correctly. So, we&rsquo;ll find out more, let&rsquo;s say, mid-December about
whether this proposed cut will go into place, and as I said, there&rsquo;s a lot of industry lobbying groups, and not just from
radiology, but all the specialties, that don&rsquo;t bill E&amp;M codes, who are facing a significant reimbursement cut. There&rsquo;s
a lot of cooperation between the various industry groups to try to push back on these cuts going into place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From our standpoint, we&rsquo;re prepared
for the cuts to go into place. We have a number of mitigants that we think will fully counteract the $11 million or so of cuts,
and we&rsquo;ll just kind of have to wait over the next 30 days and see where the government&rsquo;s coming out.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. So, just to summarize that, basically,
versus what you thought the cuts would impact you, or how they would impact you, from your comments in Q2, nothing has changed,
right, and you&rsquo;ve done more work to get to the same exact number, $11 million, give or take?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Correct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay, cool, awesome. Then, I guess, if
you don&rsquo;t mind just giving us some comments on the Arizona strategy. This is, obviously, the first time we&rsquo;re seeing
you go into a new market in a while, and it&rsquo;s quite contiguous to an existing operation, so if you don&rsquo;t mind just
describing what you saw in the Arizona market that made you decide to go in, and is this something that you think we would see
more of as you replicate that entry strategy? Arizona, obviously, is close to your California operations. Is that a factor, or
are you willing to go into new&mdash;completely new geographies?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Brian. I&rsquo;ll take that.
The entrance into the Phoenix market was really a combination of factors. First and foremost, it&rsquo;s an extension of an existing
relationship that we have with the Dignity Health system, which has now, as you are aware, become part of the CommonSpirit after
a merger with Catholic Healthcare Initiatives. We were introduced very favorably to the leadership in Phoenix and they asked us
to really help them with an outpatient imaging strategy in that marketplace. Given that we also had an opportunity to buy eight
centers in that market through an existing relationship with the Whiterabbit company that we do business with, we found a good
combination of circumstances that made it attractive to us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As I had said on previous closed calls,
while we would be interested in going into new markets, we needed, really, two factors to be part of that decision-making, and
it really has nothing to do with geographic closeness of existing markets, but more with the dynamics in a marketplace. One is
could we find a good partner to enter a new market that, like Dignity was looking for assistance with developing an outpatient
strategy, and was there a path for us, like we have in all of our other markets, to have considerable growth and be a very substantial
player in that market. We, fortunately, found both of those in the Phoenix market, which also is a rapidly growing market, perhaps
one of the fastest in the country, and the Phoenix market, where most of these initial centers are, of over 500 million people,
becomes similar to other markets that we have entered&mdash;not entered, but that we&rsquo;re already currently in. So, I think
the mix of opportunities there created a very nice pathway for us.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also, it shouldn&rsquo;t go unnoticed that
a few weeks ago Cigna Health announced that they were no longer going to be reimbursing patient imaging performed in hospitals,
except for certain circumstances, and I think that that is additionally kind of forcing some of these hospital and health systems
to re-evaluate the inevitable transition out of hospitals of ancillary outpatient services, such as outpatient imaging. So, while
this may be the first new market that we&rsquo;ve entered into since 2013, I think that there will be other conversations that
we&rsquo;ll continue to have with health systems that look to the leader in outpatient imaging, namely, RadNet, to assist them
in that process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stolper</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, and Dignity is a unique partner in
that particular market. They have tremendous breadth of operations there. In addition, Brian, to owning eight hospitals, either
owning or affiliated with eight hospitals, they&rsquo;re also a big player in the medical groups there in Phoenix. They own one
medical group that has 100,000 lives, called Dignity Medical Group. They have a 50% ownership in two other significant medical
groups there, one called Arizona Care Network, another one called Mercy Care. Each one of those has 300,000 lives, so we&rsquo;re
talking about, 600,000 lives there, and they are aligned with another medical group, called Integrated Medical Services there that
has 100,000 lives. So, between that, their eight hospitals, an urgent care center network that they own, an affiliation with Barrow
Neuroscience Institute, as well as the Phoenix Children&rsquo;s Hospital, and others there, they control a tremendous&mdash;or
they have influence over a tremendous amount of imaging, which currently is going to competitive imaging centers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So, we think, as we devote focus on resources,
as we build centers in conjunction with Dignity, as we purchase other centers in that marketplace and significantly broaden our
scale and our access in Phoenix, we believe that we have a strong opportunity to capture a lot of those lives and patient volume.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No, that&rsquo;s awesome. Then, Mark, just
from a recovery trend perspective, would you be able to share with us how volumes trended over the course of the quarter, and any
comment you can share on how things are trending through October, considering, obviously, the resurgence of COVID in a lot of markets,
and also the wildfires in California?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Brian, I&rsquo;ll take that one. What we
saw in the third quarter was a steady increase, beginning primarily in the middle of August and extending through the end of the
quarter, September, and by the end of September, we were approaching, on a company-wide basis, about 95% of our original 2020 budget
estimates in volume. That trend has continued and has increased slightly in October and the early part of November here. Our forecasting
of the procedural volume increases that started in early August was very instrumental in allowing us to bring back, as I mentioned
in my opening remarks, substantially all of our staff at our imaging centers, and by October 1 bring everybody back to their full
compensation. Fortunately, I believe that the benefits that we saw in the third quarter, some of which were as a result of lower
salaries and other accommodations made with some of our vendors, have now allowed us to anticipate the increased costs from going
back to normal staffing and what we&rsquo;re expecting to be a nice increase in revenue for the whole of the fourth quarter, as
opposed to the somewhat average and lower volumes for the whole of the third quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That&rsquo;s awesome, Howard, and then,
I guess, just the last question for me is a follow-up on that. Howard, how are you thinking about the durability of the cost savings
initiatives that you&rsquo;ve put through? I know, Howard, you just said that you&rsquo;ve reinstated a lot of the compensation,
so how should we be thinking about the cost structure as we look at Q4 and going forward? Thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay, Brian. Well, I think the pause, as
I referred to it, during the second and third quarters has allowed us to look at many factors of the Company&rsquo;s operations,
which I think uniquely was created by the markedly reduced volumes that we saw in April and May predominantly. Because the Company
had grown so rapidly, primarily through acquisitions, we found that we did have a number of centers relatively close to each other,
that patients, given the circumstances, were willing to travel to more than we might have thought in the past. So, I think coming
out of this year, we have created a lot of operational efficiencies both from the staffing standpoint and the number of facilities
that we need to operate, and I believe the combination of those will create some improvement in our performance, which we mentioned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think, perhaps, the best way to look
at this, Brian, would be that the margin expansion that we saw in the third quarter is what we&rsquo;re going to focus on to try
to replicate in forward-going quarters. Of course, that&rsquo;s subject to, perhaps, some of the cuts in the Medicare reimbursement,
should they go through, which will hurt those margins a little bit, but I think the additional cost savings that have not been
fully implemented, that we anticipate in 2021, will help mitigate that, along with sustaining what I think is better workflows
and efficiencies in our staffing. So, I think, perhaps looking at our margins going forward would be the best way to estimate what
the sustainability of the cost savings are.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Brian Tanquilut</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Awesome. Thanks, Howard.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Brian. Take care.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will now take our next question from
Mitra Ramgopal with Sidoti.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, hi, good morning. Thanks for taking
the questions. First, I&rsquo;m just trying to get a sense in terms of the volume rebound you saw. Clearly, the environment is
much better with the easing of the lockdown restrictions, etc., but I was curious also if you&rsquo;re seeing any benefit as a
result of maybe some of your competitors not being able to survive the pandemic.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Well, I think the&mdash;good morning, I
should say, Mitra. I think that there&rsquo;s two facets that answer your question.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As far as our competitors are concerned,
I think that the impact of COVID will be something that we&rsquo;ll see more of in 2021, as some of our competitors who have not
had the financial resources that we have, as well as potentially the moving cuts in Medicare, force them to consider the viability
of their own businesses. I think the liquidity position that we&rsquo;re in has put us in a good position to potentially take benefit
from that.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As far as volumes are concerned, I think
there is a myriad of factors that play both ways on that. First of all, I think it should be understand that our volumes have come
back substantially to the pre-COVID levels. I believe that there will be a number of people who still remain reluctant to come
out of (audio interference), and I believe that will stay that way for probably well into 2021, when, hopefully, as was announced
this morning by Pfizer, we come closer to a vaccine that is not only effective, but will be sought after by the majority of people.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do have some anecdotal evidence that
that is, indeed, the case, because one of the largest portions of our business, meaning the x-ray business, is the one that has
not as yet returned to the pre-COVID levels, and I believe that&rsquo;s explained by the fact that there is still a number of people
who aren&rsquo;t accessing their routine health or physicals or rather minor problems, and, number two, elective surgeries are
still down, and those people who traditionally get chest x-rays or other procedures (inaudible) their surgery is also down. So,
I think those will trail and they&rsquo;ll rebound more in the second half of next year. Fortunately, x-rays are not a major driver
in our (audio interference). The flip side, I believe part of the return to normal volumes is the fact that people were not accessing
their (audio interference) were not accessing healthcare as necessary, and now seeing that little bit of rebound from that pent-up
demand. I think those two kind of counteract each other.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Somewhere in the mix there, I think you
put into the factors that people like Cigna and other health insurers are continuing the make major drives or directing people
away from hospitals, and people, themselves, perhaps now look at outpatient ancillary services, particularly imaging, in a little
bit more of the rational light, given the fact that they prefer not to go into the environment of a hospital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think all of those factors have weighed
in and will continue to improve for us, particularly going into the latter half of 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay, no, that&rsquo;s great, thanks for
the color on that. Then, I&rsquo;m just curious, on the margin&mdash;obviously, we saw really nice EBITDA margin expansion, and
you&rsquo;ve certainly rationalized the business with the COVID impact. I was just curious, going forward now, how quickly we should
expect those savings just to continue to flow through versus maybe balancing the need to&mdash;or some of the growth opportunities
you&rsquo;ve talked about, whether it&rsquo;s in mammography and elsewhere.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Well, I think mammography&mdash;and I&rsquo;m
glad you mentioned that, Mitra&mdash;it has been, and will continue to be, a major focus of the Company&rsquo;s efforts. In the
collaboration agreement that we announced with Hologic, part of that is to take almost our&mdash;all of our 300 mammography systems
to the new Hologic high-definition platform and make those a unique state-of-the-art opportunity, that will be the first of its
kind, really, in the United States, and then putting on top of that the artificial intelligence that we hope to have. Getting approval
from the FDA in the early part of the year will allow us, I think, to have a competitive advantage, as well as expand the offerings
that we have in a way that&rsquo;s unlike any other operator out there, whether it&rsquo;s hospital-based or outpatient imaging.
Putting those together, currently being about 4% of all the mammography in the United States, and we believe putting our centers
with new technology and our own artificial intelligence, will allow us to expand and increase that percentage even more than it
is right now.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So, I think you can look to the mammography
portion of our business to continue to grow disproportionately to the rest of the business, and in and of itself, I think is a
potential harbinger of where we, as a company, want to go with other screening procedures, particularly for prostate, colon and
chest, to make these similar to mammography, something that can be ordered individuals themselves and supported by the insurance
companies as part of a wellness (inaudible), hope to advance in 2021. I expect that you&rsquo;ll be hearing more of that from us,
also.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay, no, thanks. Then, finally, as you
mentioned, you&rsquo;re probably going to be the best placed operator coming out of the pandemic in the industry. I&rsquo;m just
curious if we should expect you to be even more aggressive in terms of expansion plans? You&rsquo;ve obviously just announced a
new JV and an expanded relationship. I&rsquo;m just wondering what the pipeline looks like, and also the appetite for M&amp;A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Well, the pipeline has always been good
here. Generally speaking, we don&rsquo;t go knocking on doors looking for acquisitions. We want motivated sellers, if you will,
or opportunities that come our way, and we expect that those will increase in 2021. Particularly, if the Medicare reimbursement
cuts are implemented, I think it&rsquo;s just going to make it that much more difficult for the insurer mom-and-pop and smaller
operator to be viable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will remain disciplined. Part of our
growth strategy, since we&rsquo;ve achieved leverage ratios that we&rsquo;re very pleased with, and hope to even lower, we need
to continue to be disciplined about how we do our acquisitions to make certain that the Company does not leverage itself higher
than what we believe are comfortable levels, and, in fact, that we&rsquo;re looking to improve upon (audio interference). If we
had a disciplined growth strategy, it may very well be, particularly on the East Coast, where we have imaging demand in some of
our markets, particularly in the New York marketplace, then we may need to build more centers if we don&rsquo;t find the opportunities
for acquisitions (inaudible).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mitra Ramgopal</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. Thanks again for taking the questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. We&rsquo;ll now take our next
question from John Ransom with Raymond James.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>John Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good morning. Mark, the $11 million that
you cited, does that include all the commercial contracts also tied to Medicare, or is that just Medicare?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stopler</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That&rsquo;s just Medicare. We have very
few contracts that are tied to Medicare. When we were living through the Deficit Reduction Act, and the seven/eight years that
followed, where Medicare was hitting reimbursement, we did a pretty good job of unbundling most of our commercial contracts from
Medicare. We still have some, John. For instance the Medicare Advantage Plans, for the most part are still tied to Medicare reimbursement,
so those will adjust, but it&rsquo;s not going to be a material amount, maybe another couple to few million bucks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>John Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. My second question is&mdash;okay,
let&rsquo;s just assume that it&rsquo;s $13 million, $14 million bad guy. What&rsquo;s the good guy in terms of fully realized
cuts in &rsquo;21, versus a partial year in &rsquo;20?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stopler</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Say that again, it was a little tough to
hear you. The good guy as it relates to what?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>John Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Just the timing of having your cuts in
place for the full year versus a partial year. In other words, we&rsquo;ve got&mdash;make up a number &mdash;$10 million. We&rsquo;ve
only got $6 million in &lsquo;20&rsquo;, but we&rsquo;ll get the full $10 million in &rsquo;21, so the net would be $4 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We plan on having most or all of the cost
savings initiatives that we&rsquo;re working on right now in place for the beginning of 2021&mdash;and I&rsquo;m talking about
January. As we finalize our budgets for 2021, we will have the vast majority of our cost savings initiatives in our 2021 budgets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>John Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I mean, quantitatively, there is a pickup
because you&rsquo;ll have a full year of those savings versus a partial year this year, because you really didn&rsquo;t go into
overdrive until maybe what, March/April. So, is there an offsetting effect, or am I just making this up?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Mark D. Stopler</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I mean, yes. I mean, if you were to look
at the third quarter results and its margins and what we produce in the fourth quarter, that will probably give you a good indication
of kind of our run rate going into next year. Obviously, there&rsquo;s some seasonality in this business, as you&rsquo;re aware,
John. First quarter tends to be our most difficult quarter, because of the reset of deductibles, as well as weather conditions
on the East Coast, which tend to make our first quarter volatile year-over-year. But, aside from that, if you were to take our
third and fourth quarter, which is obviously yet to be announced, into next year, that&rsquo;ll give you, I think, a pretty good
indication of the type of expense savings that you can annualize into next year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>John Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. Then, lastly, for me, what strikes
me as possibly even a little odd is you operate in a couple of the toughest lockdown spaces in the U.S., California and New York,
and if you talk to, say, other providers, they&rsquo;re still seeing volumes down, call it high-single, low-double-digits, in those
markets, but you&rsquo;re kind of back to flat. Is there maybe some catch-up due to timing, you know, that people are just rescheduling
procedures and there might be another little bit of an air pocket, or do you have any reason why your volumes would be higher than,
say, physician office visits, in some of those markets or geographies, that sort of thing. Yes, you guys are just doing much better
than I thought you would, just give your location.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hi, John. Yes, I think what&rsquo;s happened
is radiology and imaging, while it&rsquo;s an elective procedure, is really an essential procedure, and I think as more and more
of the articles come out about the reduction in healthcare, what people are recognizing is the way healthcare is bad healthcare
and it&rsquo;s more costly to the system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think in the case of outpatient imaging,
two factors are involved. Number one, people have determined that they&rsquo;d rather be in an outpatient setting where the practice
of safety measures can be more enhanced than it can be in hospitals, number one, and number two, taking mammography for an example,
you can delay that, but it&rsquo;s something that people estimate every month of the way is costly in terms of the potential morbidity
and mortality related to breast cancer. So, delaying some of these procedures has been something that I think is now being recognized
as unadvisable, number one. Number two, I think, just in general, we&rsquo;ve recovered very nicely in New York, which was the
most locked down market back in April and early May, and although we saw those reductions, we saw a very quick return in those
markets disproportionate to the way other businesses are being handled. So, I think it&rsquo;s a matter of doctors going back into
their offices and more business being directed into outpatient centers than it is necessarily people not wanting to access appropriate
healthcare.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>John Ransom</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Great. Thanks so much.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. That does conclude today&rsquo;s
question and answer session. I&rsquo;d like to turn the conference back over to Management for any additional or closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Dr. Howard G. Berger</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Again, I would like to take the opportunity
to thank all of our shareholders for their continued support, and, particularly, the employees of RadNet for their dedication and
hard work. Management will continue its endeavor to be the market leader that provides great services with an appropriate return
on investment for all stakeholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you for your time today and I look
forward to our next call. I wish all of you and your families good health and safety during this unprecedented time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Operator</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. That does concludes today&rsquo;s
conference. Thank you all for your participation. You may now disconnect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" !C .<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V:BBB@ JK
M>:A;V*9F?YNR+R33+R\* I#][NWI5&'2&NG\VY9@IY_VFH S;OQ%JUY(8-+M
MMA/0[=[?X"J9\)>(=5.[4M:E@0_P+(6/Y @5VD%O#;1B.&-47T J6@#AE^$V
MAN,W=U?3MW/F!?Y"IHOA;H5MS9WNKVC?WH+]T-=G10!S<'A[6]-(^P>*;JX0
M?\LM3A2<'_@2[6_4UI07]]#\FIV0C/\ SVMF,D9^HP&7\B/>M*B@!JLKJ&5@
MRGH0>M.I JKG: ,G)Q2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %03R8&Q>O<U)+((T+'\*@B7S6R>G>@!(+8$B1Q]!5NBJM]>K9P%
MMN]S]U?6@!]Y?6NGVS7%Y<1P1+U=VP*XB[^*D4UVUGX<\/ZCK<HX+QH4C'XX
M)_,"M3_A&7UNX%[KTC/&.4M\X 'OZ#]:U7O-/T:PVV=NBQ)PL<*A10!SD&M?
M$BZQ(/"FFVR'^">]RW_CO^%:4&N^*(.=3\)DH.KV%ZDI'_ &VG\LUEW?C#Q4
MS$Z9X4>XC[%BPS^/%58_B3KVGL#X@\#ZE;0YYGM@9 ON1C^M '<6&JVFH@B!
MV61?OPRH8Y$^JM@U<K*TK5M(\2VJ7EC,DX3IQM>,^A'45JT %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% &9J%S_I"P@_=&3]35^!
M/+A4'KC)KG+:?[;KS+U!E/Y#_P#573T (2%!)[546)7D:YG(VKR-W08I]W+L
M\N,=9&P*YOQ_J;66DV^G0L1)?R;"1UV#EOSX'XT 6X]1EUV9EM@1;YPG^T/[
MQK:@LXH$4;0S#^(BJN@Z<-.TN*-AB1E#/]?2M*@#E]7^(>@Z)J<VG7CW GAQ
MOV0EAR >OXU#:?$[PM=S+%]LD@+' ::(JOY]!^->8_$CCQSJ9'^Q_P"@+6CX
M_P#"EAHMAIFHZ?&8DNE"2Q[B1NV@Y&>F>:Y75GJ^B/8CA,.U"+;YI*_D>NMI
MEE+,M[ B17!&1/$ "P]\?>'UJ6>\2SL9KJZ.Q+>,O(1SP!DD5ROPLOY;WP;'
M',Q8VLS0J3_=&"!^&<?A5GXDWOV+P1?8.&N-L"_\"//Z9KH<O=YCS8TFZJIO
MO8GT'QUHGB.^-EI[S><(S)B2(J"!C./SKHZ^?_ -]]@\;:;(3A99#"W_  (8
M_GBOH"II3<XW9KBZ*HU>6.QS.L_$#0M!U.33KYK@3Q@%MD18<C(YJK;_ !2\
M*SRB-KN:'/\ %+ P7\QFO.?BCQXYO?\ KE'_ .@"NA\4> =-3P?'K.EQ&WN(
M;=)9D#$K(N!N.#T/>LO:3N[=#K^K891@IMWDCU&">*YA2:"1)8I!N5T.0P]0
M:R]7\3Z=HDXAO#+O,?F )'NXY_PK@/A!KDJW=SH<LA:%D\Z $_=(/S ?7(/X
M5I_$'_D.0?\ 7N/_ $(UO"2E&YYU:DZ51P?0[ZTNHKVTANH&WQ3('1O4$9%8
M\OC+2(=0%B[3><9Q!Q&<;RVWKZ9K/^'>H>=H\VFN?GL9,*/^F;<K^1W#\*Y&
M_P#^1Q7_ +"R?^C15&1Z?JNJVNCV@NKLN(RX3Y%R<G_]59'_  GFB?WKC_OT
M:9X__P"1>3_KX3^1KG_ ^CV.L'41?P>;Y#QB/YB, KD]* .MLO%>EZA%>20-
M*5LHQ)+NC(X.<8]>AJK_ ,)YHG]ZX_[]&K]KX;TFRCN8[>UV+=H$F&]CN S@
M=?<URWC+0M-TFPMY+*W\IWEVL=Y.1@^IH V6\>Z&JEBUQ@#/^J-;]I=1WMG#
M=PY\N>-9$R,'!&17!^"M#T[6;"]>_M_.:.X\M3N(PNQ3C@^YKO;:WBM+:*V@
M79%"@1%SG  P!0!+1110 4444 %%%% '$>#IOM&KNQY*QLWYD5V]>=>!IO)\
M57=FQ^95D3'^ZPKT6@#(OI?^*BL(.S(S?E7.^*[<WGCS0X&YC"$X[??&?Y5K
M^(7-GKVA7IXC-PULY]-Z_+^HIVNV?_$\TG40/]5(8V/H#@C^1H Z"BBB@#P/
MXD#/CG4Q_N?^@+6C\0/%=AK6GZ9IVGR&5+10\TN"%W;0,#/7'-9_Q&_Y'O4L
M],I_Z M5/#ODZ5XRLX]4MXY(H[@1RI*N5&> V/8D&N"[NX]&SZ1*"IPJO5QC
M>QZO\,=-FTWP=";A"CW4C3A2,$*<!?T /XUA?&6^VV>FZ>&_UDC3,/91@?\
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)44 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>rdnt-20201109.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOaaJeaPty552uYkxvmRyfRkqDywhn6lsgSDnR0z2kdAD -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:RDNT="http://radnet.com/20201109" elementFormDefault="qualified" targetNamespace="http://radnet.com/20201109">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://radnet.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20201109_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20201109_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>rdnt-20201109_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>rdnt-20201109_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://radnet.com/role/Cover" xlink:href="rdnt-20201109.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://radnet.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>radnet_i8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rdnt-20201109.xsd" xlink:type="simple"/>
    <context id="From2020-11-09to2020-11-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2020-11-09</startDate>
            <endDate>2020-11-09</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2020-11-09to2020-11-09">0000790526</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2020-11-09to2020-11-09">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2020-11-09to2020-11-09">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2020-11-09to2020-11-09">2020-11-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2020-11-09to2020-11-09">RadNet, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2020-11-09to2020-11-09">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2020-11-09to2020-11-09">001-33307</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2020-11-09to2020-11-09">13-3326724</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2020-11-09to2020-11-09">1510 Cotner Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2020-11-09to2020-11-09">Los Angeles</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2020-11-09to2020-11-09">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2020-11-09to2020-11-09">90025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2020-11-09to2020-11-09">(310)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2020-11-09to2020-11-09">445-2800</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2020-11-09to2020-11-09">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2020-11-09to2020-11-09">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2020-11-09to2020-11-09">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2020-11-09to2020-11-09">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2020-11-09to2020-11-09">Common Stock, $.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2020-11-09to2020-11-09">RDNT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2020-11-09to2020-11-09">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2020-11-09to2020-11-09">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140311747430984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 09, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  09,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RadNet,
Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3326724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1510 Cotner Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(310)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">445-2800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.0001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RDNT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( *.H:5$'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "CJ&E1:>?O=>X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)^FJ8.CFHGA2$%Q0O(5D=C=LTX1DI-VW-ZV[740?P&-F_GSS
M#4QKHC0AX4L*$1,YS%>C[_HL35RS/5&4 -GLT>M<ET1?FMN0O*;R3#N(VAST
M#J'A_!8\DK::-$S *BY$IEIKI$FH*:03WIH%'S]3-\.L >S08T\91"V J6EB
M/(Y="Q? !"-,/G\7T"[$N?HG=NX .R7'[);4, SUL)IS90<![\]/K_.ZE>LS
MZ=Y@^96=I&/$-3M/?EO=/VP>F6IXPRLA*GZW:83D-Y)??TRN/_PNPCY8MW7_
MV/@LJ%KX=1?J"U!+ P04    " "CJ&E1F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M *.H:5&ZP-19*P0  "$0   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MG9A=<^(V%(:O=W^%ANG%[@P)EH 0=@@SA"1;9K,L#;0[TTXOA"U $UMR)1F2
M?]\C0VRZ-<>TN0C^.J\?G2/>(S'8:?-L-T(X\I+$RMXT-LZEGUHM&VY$PNVE
M3H6".RMM$N[@U*Q;-C6"1WE0$K=8$%RU$BY58SC(K\W,<* S%TLE9H;8+$FX
M>;T5L=[=-&CC[<*37&^<O] :#E*^%G/A?DUG!LY:A4HD$Z&LU(H8L;IIC.BG
M6];Q ?D3OTFQLT?'Q ]EJ?6S/YE$-XW $XE8A,Y+</C8BK&(8Z\$''\=1!O%
M.WW@\?&;^D,^>!C,DELQUO%W&;G-3>.Z02*QXEGLGO3N9W$84-?KA3JV^7^R
MVS_;Z31(F%FGDT,P$"12[3_YRR$11P%M>B* '0)8SKU_44YYQQT?#HS>$>.?
M!C5_D \UCP8XJ7Q5YL[ 70EQ;CC66V$&+0=2_D(K/(3=[L/8B;"IWEZ2H-\D
M+&#!/\-;0%!@L *#Y7IM#(/\,5I:9Z!0?R*2[4*RG4MV3DC>Z3"#Z>/(XC45
M52/$PZ\OOB 0G0*B@ZJ,@"#**1YBOJZBP.-7/+8"X>@6'-WSDC$31NJ(W*N(
MP'RIS NNE%>^WWS_[EU-Z:\*M"M4\%XYZ5[)@XP%F6;)LGHZXAI!0"_:[7;0
M0WAZ!4_O')XGL99^,D+.ICRI3!2N\\2CJ7#-]Q,57B)8UP76]3E88RBBX3&9
MJ$B\D"_BM0H,5PK@K]</NNP*P>H76/USL!;\A4PB8),K&?+<;T_7$E>D;2@E
MN^JQ#H)'@]+?@G, H0K:I-KD;$TR=S#YB39DK#-(*.151Y4UKE&_N\<@CTR8
MG@,YBB(CK&V^'9!'>(Y\4]5DN"3MT@!&Y13XZF@K5(;9""U]FK+_1#KV9Y#'
MA=ZI2DI<[E%;,E)K:-(6PRL]G^*N_2->4>>9T5NIPNI,XIKC$896=@**6_F/
M:#-M'7R1?Y?IZ<F'*_:#@'4QMK([4-S4\RJ.8%5W&@47^-"FP4<,I>P&%+?R
M1QU"5F8;K;!V4"/2Z70OV'6 M2=:]@.*&_EW(YT3"E*3))DZV)NMI,*%ZIHY
M+7L!Q2U\KF,92B?5FGR%"6XDCRMY<)5:GK()4-RS9T9<A) > =^P_9H+ECU@
M/-]6JQ/UP_7JR%AI_PPWZ'^13:S-@*P.L$:V%K"T?H;[]$(Z6/CH%:'LP_(C
MF8LP@_E6V=9KE/S\A+X[=SI\;I*?+J'-4Y)R0[8\1MV?':W2<;M>&![Y23=_
M39:Z<LK5"#S=31<826GT##?EMSR1^Y=PPZ&#G%REU0A-1_.[T2\84^GP["R'
MOT^$6?LL?08%M_&^D7)57='_N?IO'6WX_.;Y*_=OM"06*Q *+GO@UF:_']V?
M.)WF>\"E=K"CS \WL(<7QC\ ]U=:N[<3OZTL?A48_@U02P,$%     @ HZAI
M48.II0/4 0  ,@8   T   !X;"]S='EL97,N>&ULU57;BM1 $/V5IC_ GD1V
M04D"*BP(*@L[#[YVDDK2T#<[E3'9K[<[G=NX#*@/HB^3.J>J3YV^3M;C).&I
M T R*JG[G':(]BUC?=6!XOTK8T'[3&.<XNBA:UEO'?"Z#X.49.GI=,\4%YH6
MF1[4@\*>5&;0F-,39476&+TSKVDD?"E70"Y<YO0#EZ)T8J[E2L@ITFD@*B.-
M(^BM0$Z3P/3/,9U$%%PN.DIHXP+)8H?X6R[E/R56U'LHI-P,IC02168Y(CC]
MX,%</),O4F2)SY/U#EO'IR2]H_N ^>.;E,;5X+8V"5VI(I/0!#M.M%WXHK$L
M)!&-\D$M>&LTGSVL(Y; RU8@Y5/8PJ_-E?;8D+@7'^NP#21,=0V]H26,,A$$
M_:-:U#[(WOV1++'B8O#]X&>C9_QM, B/#AHQSGALMOZWU)/;ZMQ:.;V3HM4*
MXMQ_N6&1\74<Z8P3S[Y;."F5)\!1<@&'HCHRWQVW9QAQ/4UC<]MS^A]Z_KOK
MW((&Q^71M#_Z__(J_XYCMMR>PQ6]NJ ;2\)#F-,OX7V5NP=2#D*BT OJ1%V#
M?G%/O3SRTC_@5_J^OH:&#Q+/6S*G>_P9:C&H-UO58UB7I6J//X7W*+F?&^[_
M$L4/4$L#!!0    ( *.H:5&7BKL<P    !,"   +    7W)E;',O+G)E;'.=
MDKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<
M'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X9
M9K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.5
M6QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,
M<6*T_C6"R0_L?@!02P,$%     @ HZAI4:K$(A8S 0  (@(   \   !X;"]W
M;W)K8F]O:RYX;6R-4=%NPC ,_)4J'[ 6M"$-45Y VY"F#8V)]]"ZU"*)*\>%
MC:^?VZH:TE[VE-S9NMQ=%A?BTX'HE'QY%V)N:I%FGJ:QJ,';>$<-!)U4Q-Z*
M0CZFL6&P9:P!Q+MTFF6SU%L,9KD8M;:<W@(2* 0I*-D1>X1+_)UW,#ECQ ,Z
ME._<]'<')O$8T.,5RMQD)HDU75Z(\4I!K-L53,[E9C(,]L""Q1]ZUYG\M(?8
M,V(/'U:-Y&:6J6"%'*7?Z/6M>CR#+@^H%7I")\!K*_#,U#88CIV,IDAO8O0]
MC.=0XIS_4R-5%1:PIJ+U$&3HD<%U!D.LL8DF"=9#;E9T!N[RZ .;<L@F:NJF
M*9ZC#GA3#O9&3R54&*!\4YFHO/93;#GICEYG>O\P>=0>6N=6RKV'5[+E&''\
MGN4/4$L#!!0    ( *.H:5$D'INBK0   /@!   :    >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S(Q(2Q:X*
MMR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\ I%NTBB[.XS!/:A>L
MXEF&!KS2O6H0DBBZ0=@S9)[NF:*<//Y#='7=:7PX_;(X\ \PO%WHJ45D*4H5
M&N1,PFBV-L%2XLM,EJ*H,AF**I9P6B#BR2!M:59]L$].M.=Y%S?W1:[-XPFN
MWPQP>'3^ 5!+ P04    " "CJ&E199!YDAD!  #/ P  $P   %M#;VYT96YT
M7U1Y<&5S72YX;6RMDTU.PS 0A:\295LE+BQ8H*8;8 M=< %C3QJK_I-G6M+;
M,T[:2J 2%85-K'C>O,^>EZS>CQ&PZ)WUV)0=47P4 E4'3F(=(GBNM"$Y2?R:
MMB)*M9-;$/?+Y8-0P1-XJBA[E.O5,[1R;ZEXZ7D;3?!-F<!B63R-PLQJ2AFC
M-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U
M.EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*
M$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87
M_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( *.H:5$'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ HZAI46GG[W7N    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ HZAI49E<G",0!@  G"<  !,
M         ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "C
MJ&E1NL#462L$   A$   &               @($-"   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ HZAI48.II0/4 0  ,@8   T
M         ( !;@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "CJ&E1EXJ[
M',     3 @  "P              @ %M#@  7W)E;',O+G)E;'-02P$"% ,4
M    " "CJ&E1JL0B%C,!   B @  #P              @ %6#P  >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ HZAI420>FZ*M    ^ $  !H
M     ( !MA   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ HZAI4660>9(9 0  SP,  !,              ( !FQ$  %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  Y1(

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="radnet_i8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://radnet.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="radnet_i8k.htm">radnet_i8k.htm</File>
    <File>radnet_ex9901.htm</File>
    <File>radnet_ex9902.htm</File>
    <File>rdnt-20201109.xsd</File>
    <File>rdnt-20201109_lab.xml</File>
    <File>rdnt-20201109_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "radnet_i8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "radnet_i8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rdnt-20201109_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rdnt-20201109_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "rdnt-20201109.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "RDNT",
   "nsuri": "http://radnet.com/20201109",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "radnet_i8k.htm",
      "contextRef": "From2020-11-09to2020-11-09",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://radnet.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "radnet_i8k.htm",
      "contextRef": "From2020-11-09to2020-11-09",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001683168-20-003793-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-20-003793-xbrl.zip
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M B#6P/LI?Z;X+S^^M3R\G9 0.JF[WC]?G%_?=DGKYFO[NMV-[B\E-_83&S[
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MF@&J<Q;(T1ODX'_Q(\<=A!TN9<*A<=FZ;X.4T#R@<>34#/'2!/HF7^ BW"^
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MGV604N!)UR]^B. 1\D">U,W+I(%R>3[G Z:$8QJ<:C';%P$EU=$&O.SJF3V
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MXTG?*?'T\ >L5W8L$5 *KI'E]WRXPX/H@L#+H+F>CWX%V&3NFV=3=(PNG@<
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M:Z9]$X;K^OR P62UV#,<_(,79OGBCV%-9"9W-CUPL)WNNK4A627LZ2.7+)O
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M5N*):MYBI)K7$>];C)7W%I>SO2,DFX=$H@!PQA_G7VS;XQ-S/G_XD5:=)TH
MHS].N= S?,J4C FJ6T&#MI_Q\EEYD,_U!HRKQJHUQD$EA@4 S(@MHKJ$J0YV
M''.)*& /VW10XJ&[EL*],ZY"->(JI'"_-A"=7[$SMV'Q41@X9Y?_[N9S_);@
MN>@--FT7YQ?!7X]HG:%+"UN%Q.:X4CE)VQ#>8WDGP.6HH.V+D0Q,&G:4C^2
MCSB=S3?<@9S9;.GYG!68\BR843BQ%PJS6R+E*#[4]'4 4]X4;I-A$1^;D'.U
M2,4;)R_+M\?U'P!"#9]NFK86; .^6;"&F#]P-G<  3X EG -W0")#PB\XM@I
M?ZCA3N]Q^,[P-USFJ" 4#$MUQN(\;(N=>8"!A#WQ??+4G\PB(Q 5+-Z]I1#J
M%H= 1K,D #L'Z&U;FF$R/AG"@/VPX*C@,/(YQ!75X8%+7K0O6[V"#3-DJNL[
M+(9 _"CX_L^_00P35!%75'/,U5PX<AW^]>"L'L8R.@KO8JF/W$821X;G,6"J
MZ0TTE9.I#D]UQ@BQBO0$!.R[2.0N'EL?E41+8Q/L")\/B&AR1^4CP_&KJF;(
MB=CJ ^_+C2NZS'DR$!> J KYW.PKN@/;-W4<209< ^D>L)7A'*2IITQ>/0(0
M$ ]<RC=3P(;O!7;E$"CM%R<Y77"3F6?F<PL?BH,9@1H%@X(]Q+TU@9HL^.:)
M"6J##15LA(I&OGW3?G;)([.0=$477TG&UB.-S'F$Y<+NOG .87M?_$%PI\E;
MNAXLQ6?& %]0"7!-%_4/#B"^Y133F'.;*[ B@@V+-A&X"3!# SB3#@<&*!CG
M['#DN%/A@0BX&&S+$)"$PZ1J&G %?BC/AC<0""[1!5]-R /7=S4V\@P9NP<S
M9,SW8LB\@:V[8HBOJ?FFE ?> &Z''QU#H_A"X3900.GQY/A"NH)%Q4ZZ!IA,
MJF,"!AH>$J,$G3]#7,)OLV#_"WO-C+;;(2)!VZ+FL6W1#MH6-8]MBS),5''#
M)F+'O)NC#<U+81,/17-X<T^^:_UU>T\NKUO=+KFX;[?^[]7MGS>[ T?L-Q'_
MY'-3'Q/\L^B@$@,Y[SW7 /QEZ;S)D6DU0ZL5WZ>;S;LLRQ+[Y!B.3O[EJPY\
M?$W6X:%DM.XV0W0K*9Z5ZMQ,0,S%Q/DLH&UV+%"]4#?\("*I=Z#>H0IYCQ:C
MSQ8(J%=E.BX5O(O2':OU0BP?9.E3WF\\#G;^G:'"[J0>_R\IA03=)E[_@LOZ
M+5^J(\/;3JBU5$C0)6'SQ[GX67_:SD_FN%,!YP]W\ T?!MRQ_O:=]&>5[1X%
M!+H;<ZL^-ONJ"6+;VSO_!6%MSAX_W.!X6,$B]SFB6R[$TE<2QG/31;F>[:EF
M^KD=Q?4YSH;"5]F)HF09DF7J^];M'M&=E8 UAMWMN_G<Q5_D^^U5Z[K3^RN
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M.4L1M0G%B/B7>$E53];< II=-N6:_ /UI&Q)<>?)X-ELQ1.5X-CQ,7>Q#?T
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MI'+:  L0IKINZ^4._%/LQE<&B0#Z #8A3;)*,CZ@5W,KJ#M;"NZI:Y@(,$B
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M5JM5=.:J@TJ$9\O$4RE[_8FM14%)'1XFH+'-HL[G#(1VPK4Q/BG,C5,[Q:H
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MRF PTY"4+B-E4^Z?\9S3/V 0(5K5J)"+/X[3R:HP$ASS*#-%Z[!0TV=RH3L
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MKI0V4,ED:+VM)B\[I\A 45=_)4NOE+6W4G0I=J[P<59I!Q:NB!DNFJUT&)K
MS(*M"L$ZSMC-\NL\TQ)@SAH4 HR.I63P6;%%"@2T9,2:DAU$3:@?Q,*#ER+R
M[J1>LK&@67@\*G0YKX_U$EE$%),=S'D%P7PT4FT'0HV,VZ*I1K+[[][RF\3&
M3^YBXY\C-GYR%QO_'1^L/Y;/I+QJG".$B_!IX(^]M][L2OL001]"C.DY?9("
M$TAE0>D-U;1\S7N% #H5U%5BFPU\,2CHJ;7:EL&'X:Y,SCWE5P<-T:S(1FN:
M_+J/N0Q).-2YLOEK\E/L@?!.'?&#!*..-!UHN3_\0VF"5%VE;V*&_F&ODYNJ
M%!H@7Z(VV>9;4JA+R1UMV.NMW$..Z@=EQ]N\%8_E*ZZ(=S:2R_V/Y=WH+;?D
M?#(B 0X*+<4@7#/?V9)+3>Y0(U%IM[F40X]1]ZJL%E=J4&<5'. ]+NLHN5*J
M9C U8T5F+:<>DC);,.N+%N^! 4::(TS+ 86Q:5UU3; -[;PA&.NG4? QYC$1
M5?9MI+C[BK>'\\:X4*^$=7J96P&=X6UBJ:'DQ PK^[DK'P0\-)]ZU"W%JUO/
M=Z*A(_IZ<T0#.=I66]'H-R!U!&NGDTXB08#U&1.XX":"DI !N,BWV(Z9K)*:
MC<S<">]LH#D7HM^8!QB,3B1>,P[Q,\D,.\,\]"I<"LQR1(O)O@NI0<+$3&KZ
ML(QF<AK/3\^NK;ZC+NZL.C#@QY8*)T(U&#:\WQ&.V=E[FM2Q1P]9 9[XWHL]
MRPXTRT$!)/ZJ2\?Y/"3<N($OD 'L$;J!W5^(1*7[$^#.911]XMK(A\/E%TMF
M_.*R,;U1[RT*XH=F)_/+OBGX,WMFLD8J7H#)X;PRC>=<]WXJ)8&2J#7&H$YZ
MH(HB?OI^.%-:Q5;\"32D$3UD*KX^Y/^:G<\Z%CY*/I&>6G(Y%&E,Y<\^M7Y,
M8"C-8@-Z).?RCZ%9^MP9LS*2EJP9-$D_@68T:_HI\]\^3_8B-(O@F-K+B@-K
M8)06E_Q0K4O:XR7)&/'WO3.[#>!'/Y"A/**%C\8YNK7_KI<-)URM.+]Q;69!
M*+*S.F?]C:];B7F5BZ++K(\[,+MJS1$!9I"F&U0Q;B3]^?((D.RJ%C28T?+B
M[IOQL)Z^"JS]I#"-4G ,-'BWAJ%$.-09NO7I-6%#2 88 CV#30&*5-$W&.!7
M2$W5F,/TN47 J4W>@>:&1='9H@TE:1JHGU\([SH"A*XPA5!<8>^*PN3M%4 L
MUGFKY?ABS@M'6F, T&K;G0#X?Z[F4*N[<MZ562%.^\9IVH>WOZ80QS,C,%,/
M"TY9E#)&D_E#C41+HVZ>N<AE\A:.C=0;0/QV#DO@9]+N<%;WR3RJV,0S&99.
M0-J1109U.O;[(+).NA[&)KSNJ<)$'*W^HNJVD@:*U7;"8]XMKN[N@M_%<1:M
M[M7.H8C];9][ZG]X%*>3P@Z.O6D:Y#G+E1"^NW?R(-0NOW?R,&P*<$IU.V%$
M#CFB !+AD-%7/;>>D+\ F #PE'H5Z ?Z))(:%+ADQ+2A/<KP@.@WQR.Y5N[>
M\IM$T$[O(FB?(X)V>A=!^QT?K/%KN.]=5AT[.=A')Q3]FD#2BF):P==O:K&A
M+^-K#'3UK821+#LRX80<R54T<G7H!\><V^8;Y5Y9,XY:F5!$">&JG8M [@Y=
M192/@RH)8TY%7[XA0<^4E<$+OZI:U;38W]UM0Y*<?G[OQ)?,C+PUUT@;+3E0
MVR;W'GL]"_I/H?J/_E23,2,_S\JVH>=1^P,-JW'PU#80UMWS*MUX-/P_2 B3
M(^1<]T;VM)BQ=<C%$59!%&20W($]+N<X)@*F1 U>>L F]D__;(0R)II^<P@.
MGO2*O$TG/YBR,\ ,G#5:(IC-  5$HHZ(T#=I<K,:M<KM:I-K!$OB_&*QTR.^
MQ'A@FOF(MESCX]G9GUA8?ZH<,J0ZIR!"+=N\-4(CG(9D8Y*_^>(*N9PND;H'
MOU28>!#;/A'-[8_#IF7$ QRUZ]*$LKQ?+Q<Y:"2BJ2G.8DPZZFNA_I,;274P
M]6+]!=,S"Y=H[JM0 _^[;!0F+UGU[#TUF^1"[.^-"[S00]UV/.K%V-5+MWEW
MPC$B?S@(!Y><[/$0#XF$A:E-,,PHP[-QM+NA4 TP7" $=U'>8;F9D!(2P%[8
MH.B!<I8 .+U@%!03I+B\9\C)NBN!$[#]"O4^Y_Q-KSA:Q ;&4>G&FH83XEJ-
M08-X-\#3FSX6S=P@:$#7@7A*.7'%S0.*7;ER]QSGAG@/8!$_6,^DX)+4Z5#A
MCTR<R?/"-KW,D!MKU+-92M(_UT<_$(,'!S(ZX9$*Z,6RU\?K"DBR0O)6CB )
MCF22GB$=SB"9/N2?[VT"%X=C:HY:$BF&2RG=H$D,.#>P.:CWUH'=TL$J]1(J
MH0WJZD?)-#T/.%)QW7[PA8;(R%?X'=,@]HB<79(#]:"3FWNP348CK<9L#+F(
M/_"CJ"2",RTU1%(1->"AO + 8V.%F*EI<D@3Q@-Y>[G*,NQ0[ GEKI?<*HT=
MN/T$JQH04\]SV6S-PGJ6\K_/WL_2J$XB'P>'7]':BGJ H$PR]3GS%'IN#I"O
M "[7]BHU2_A$>2(<8X60@:!(,"QYSL@#WP1(!5 U):LZDAM'6;[*VT:SYDA[
MH'EP8!O86SU1YB2HJS.V+)"D?.'N^XAUDX[98HW"+)D I\02E>(H4BXEYEA
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M(11A@]M*6*(I4TH4>?D<(=+3ZF!"0>@D%.9T8@>56*0NV'P*!OD0GU<+/1Z
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MYE_<1S#&.@/C,*'S<QDNY9Q"4S\0<77'9I!A>XO-Y8!XJ8I^N?Q""O(01I,
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M2LD^H/ %4+^6&9;YQA2=-=$CWY-'"KS'3<K$TJ^>.V;BT"O,L>!)\M5:F2\
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M+FAT;5!+ 0(4 Q0    ( *.H:5$S,=*?/ ,  (D,   1              "
M ;JA  !R9&YT+3(P,C Q,3 Y+GAS9%!+ 0(4 Q0    ( *.H:5%X3<O@_0H
M -^'   5              "  26E  !R9&YT+3(P,C Q,3 Y7VQA8BYX;6Q0
M2P$"% ,4    " "CJ&E13]HTQ%0'   P60  %0              @ %5L
K<F1N="TR,#(P,3$P.5]P<F4N>&UL4$L%!@     &  8 ?P$  -RW      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
